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In case of profound sensorineural hearing loss and deafness, cochlear implants (CIs) partially restore 
hearing and provide missing auditory information to the brain. Electrical stimulation of the spiral 
ganglion neurons (SGNs) enables speech understanding in the majority of the approximately 500,000 
CI users. However, the utility of current clinical CIs is limited by their wide current spread resulting in 
limited coding of spectral information. As light can be better confined in space, optical CIs (oCIs) 
promise lower spread of excitation in the cochlea which might enable better speech comprehension 
in noisy background as well as music appreciation. 
This thesis focuses on five key aspects for development of future CIs in research and clinical translation: 
(1) Characterizing a novel ultrafast optogenetic tool in the mouse cochlea: Chronos, a 
channelrhodopsin (ChR) supporting high temporal fidelity prerequisite for auditory coding. (2) 
Improving spiral ganglion neuron (SGN) expression levels and SGN targeting by the recently discovered 
adeno-associated virus (AAV)-PHP.B. (3) Enhancing ChR trafficking to the plasma membrane 
(Chronos—ES/TS). (4) Evaluating cochlear space for optical probes in common animal models 
employing phase-contrast X-ray tomography thereby providing a comprehensive library for 
morphological parameters relevant for CI development in rodents and non-human primates. (5) 
Establishing first multichannel oCIs based on microfabricated light-emitting diode (LED) arrays in 
channelrhodopsin-2 (ChR2)-expressing rats and their functional validation utilizing auditory brainstem 
responses (ABRs). 
Taken together, the thesis demonstrates feasibility of optogenetic cochlea stimulation by expressing 





“We are the first generation able to decide what organs and senses we want to have.” This slogan by 
the Cyborg Foundation raises hopes to enhance body functions beyond the natural capabilities of 
human bodies. Founder Neil Harbisson was born with an extreme form of colorblindness, which 
restricted him to perceive his environment in grayscale only. Since 2004 he has an implanted antenna 
which allows him to sense colors in the visible and invisible range of human eyes via audible vibrations 
inside his head. This permits him to not only extract colors used in daily live but also to tell the amount 
of ultraviolet (UV) radiation at the beach. The osseointegrated device implanted in Harbisson’s head is 
a hybrid device of a bone-conducting hearing aid and a camera. Thus, the so-called cyborg antenna is 
not a neuroprosthesis by definition, but still illustrates the intention and purpose.  
Neuroprosthetics offer the possibility to link medical auxiliaries to the human nervous system via 
neural interface to partially restore body functions. Often the field of neuroprosthetics is seen as a 
brain-computer interface only, but it offers far more: missing biological function can be replaced by 
medical devices to regain quality of life. Today, patients with diverse deficiencies in their senses can 
partially regain function. In the field of vision restoration, the retina implant has proven the most 
successful. The bionic eye electrically stimulates the visual nerve circumventing the degenerated 
photoreceptors, as for example in case of retinitis pigmentosa or geographic atrophy. Another 
prominent example for neuroprosthesis is the deep brain stimulator (brain pacemaker), which uses 
implanted electrodes in the central nervous system (CNS) to treat movement and neuropsychiatric 
disorders. The most successful clinical neuroprosthesis, however, is the cochlear implant (CI) which 
this thesis will focus on. 
Despite all efforts in neuroprosthetics one should not underestimate the capabilities of the brain, 
which likely explains much of the success of e.g. the CI. Neuroplasticity, the ability of the CNS to adapt 
and rebuild synaptic connections in a stimulus-dependent manner, plays a major role in the great 
success observed in human rehabilitation. The reformation of neurons enables the brain to integrate 
new inputs and rebuilt a functional perception. Therefore, neural implants are most successful, the 
more peripheral the interface connects to the nervous system as this enables medical devices to make 




1.2 Cochlear implants 
1.2.1 The auditory system 
The outer and middle ear: The adequate physical stimulus for the ear is sound. Pressure waves are 
collected by the pinna of the outer ear and directed onto eardrum that connects to the ossicular chain 
in the middle ear consisting of malleus, incus and stapes (Figure 1). The middle ear conveys the 
pressure waves to the fluid filled cochlea via the oval window. This mechanism is required for signal 
amplification because otherwise sound would be strongly attenuated due to the different inertia of 
gaseous and fluid media. 
 
Figure 1. The human ear 
Frontal section through the human ear starting at the outer ear (top left) to the inner ear (top center). 
The three scalae are depicted as a 3D mouse model (top right) as it is the focus of this thesis. Bottom 
shows cross-sections through a cochlear turn (right) and the organ of Corti (left). Modified and 
reprinted with permission from (Purves, 2018) 
The inner ear: The cochlea itself, a bony, snail-shaped structure, consists of three distinct fluid-filled 
cavities (scala tympani, separated via the basilar membrane from the scala media, which in turn is 
separated via Reissner’s membrane from the scala vestibuli) wrapped around the central pillar of the 
cochlea, the modiolus (Figure 1). At the cochlear apex, the scala tympani and the scala vestibuli are 
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connected via the helicotrema, and both are filled with a liquid called perilymph. At the cochlear base, 
two membrane-covered windows are found: the oval window (where the footplate of the stapes ends) 
in the scala vestibuli and the round window in the scala tympani. When the footplate of the stapes 
moves, it also moves the oval window membrane. Perilymph in the scala vestibuli is pushed towards 
the cochlear apex and in turn pushes the perilymph in the scala tympani via the helicotrema towards 
the round window, which is bulged outwards. 
Since not all intracochlear structures are rigid, pressure waves cause motion while traveling through 
the cochlea - most importantly at the basilar membrane. Due to its physical properties – i.e. gradual 
decrease in width and increase in stiffness from the cochlear apex towards the base – its displacement 
depends on the frequency of pressure waves: While high frequencies deflect the stiff and narrow part 
at the cochlear base, low frequency waves travel up to the cochlear apex and mainly deflect the wider 
and more flexible part of the basilar membrane (Figure 2). As a result, a frequency-place code in the 
cochlea is established, where different frequencies of pressure waves cause basilar membrane 
deflections at different locations in the cochlea. 
 
Figure 2. Travelling wave along the uncoiled cochlea 
The uncoiled cochlea with the basilar membrane showing a travelling wave at a given instance. 
Modified and reprinted with permission from (Purves, 2018). 
Mechanotransduction: The responsible organ for signal transduction – the organ of Corti – is located 
on the basilar membrane in the scala media. It is covered by a second membrane, the tectorial 
membrane, which is connected to the basilar membrane via the rods of Corti (also known as pillar 
cells) and surrounded by endolymph. The sensory cells in the organ of Corti, the so-called hair cells, 
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detect cochlear vibrations via their stereociliar bundles. While the outer hair cells (OHCs) serve as 
mechanical amplifier, the inner hair cells (IHCs) are the “genuine” sensory cells conveying the sound 
information to type I spiral ganglion neurons (SGNs) at their afferent synapses. The stereocilia of are 
connected via tip-links. Mechanically activated cation channels in the membrane of stereocilia are 
partially open in their resting state allowing moderate potassium influx from the endolymph into the 
hair cells generating a rather depolarized resting potential. A propagating wave along the cochlea 
deflects the basilar membrane thus the organ of Corti in respect of the tectorial membrane. This leads 
to deflection of the hair cell bundles. Depending on the direction of movement this can either lead to 
an increase or decrease in tension on the cation channel i.e. a more open or closed state, respectively. 
Opening of mechanotransducer channels causes additional potassium influx further depolarizing the 
cell: receptor potential. In IHCs the receptor potential activates voltage-gated calcium channels IHCs 
causing to calcium influx at the presynaptic ribbon-type active zones. The incoming calcium triggers 
the release of the neurotransmitter glutamate into the synaptic cleft. The released glutamate 
subsequently activates afferent fibers of spiral ganglion neurons (SGNs), the primary neurons in the 
auditory system, which – if activation is strong enough – initiate action potentials. This process 
converts the mechanical sound signal into an electrical nerve signal. The somata of the bipolar SGNs 
are located in Rosenthal’s canal within the modiolus, with their peripheral neurites reach to the base 
of IHCs. Their central neurites form the auditory nerve and project to the cochlear nucleus of the 
brainstem, thus sending information about acoustic signals from the ear to the central nervous system. 
Neural encoding of sound: Basically, sound waves are characterized by their frequency (number of 
cycles per time window) and amplitude (sound pressure or intensity). While frequency is perceived as 
pitch, amplitude corresponds to loudness. As mentioned above, the travelling wave deflects the basilar 
membrane at different locations resulting in a distinct IHC activation pattern. The subsequent 
activation of neuronal populations by sound waves of different frequencies is maintained throughout 
the auditory pathway up to primary auditory cortex – the so-called tonotopy. Thereby, the brain is able 
to infer the frequency of an acoustic signal by the spatial activation pattern of neurons: pitch 
perception. Loudness, on the other hand is coded by two mechanisms: a larger amplitude leads to a 
greater vibration of the basilar membrane leading to (1) a stronger deflection of the stereocilia, leading 
to a greater receptor potential and ultimately results in a higher rate of action potential firing in the 
auditory nerve fibers and (2) a broader stimulation of IHCs, thus activating a larger population, thus 
more activated SGNs. 
This is a simplified view of hearing from the outer ear up to the first stage of the CNS. From there 
processing continues along many parallel pathways in relay stations including the superior olivary 
complex, nuclei of the lateral lemniscus, inferior colliculus and medial geniculate body up to the 
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primary auditory cortex. The central auditory pathway achieves not only pitch and loudness 
perception, but also e.g. sound localization through binaural integration. Finally, the information is 
integrated with other cortical areas in order to produce behaviorally relevant output to auditory 
signals. 
1.2.2 Hearing impairment 
According to the World Health Organization, approximately 466 million people worldwide – which 
account for 6.1 % of the human population – suffer from disabling hearing loss, resulting in an 
economic impact of about $750 billion globally spent on the treatment of hearing loss (WHO, 2018). 
As of today, 1 out of 800 children is born with profound hearing impairment, 15% of the world’s adult 
population experience at least mild hearing loss and approximately one third of the population above 
65 years of age are affected by disabling hearing loss. While approximately half of the cases of hearing 
impairment in children can be assigned to genetic mutations, the remaining ones are caused by 
environmental factors. In adults, acquired hearing loss – mainly noise-induced or age-related – 
contribute to make hearing loss the most prevalent sensory disorder. Consequences of hearing loss 
are severe and diverse: During early childhood, and especially during critical windows of development, 
the auditory system relies on sensory input in order to establish, mature and maintain the sense of 
audition. Furthermore, the acquisition of vocal speech fully depends on the auditory system. During 
adulthood, hearing impairments can cause decreased professional capabilities, risk for diseases such 
as depression, and decreased quality of life in general. In elderly, hearing impairment has been linked 
to cognitive decline and dementia. Furthermore, over all ranges of age, hearing impairment causes 
social isolation which in turn is linked to a diversity of secondary disadvantages. 
1.2.3 Hearing restoration 
When hearing fails, rehabilitation  depends on the nature and degree of the respective hearing 
impairment. For diagnosis subjective audiometry like determination of hearing thresholds and speech 
recognition as well as objective audiometry like otoacoustic emissions or auditory brainstem responses 
(ABRs) are used to classify the hearing impairment in severity and etiology. Depending on the extend 
of hearing loss, ranging from mild (20-40 dB) to moderate (40-70 dB) or severe (70-90 dB) form, 
patients might benefit from hearing aids, middle ear implants or bone conduction implants. When 
these treatments fail, in case of profound sensory neural hearing loss (SNHL, 90-120 dB) or in the deaf 
a cochlear implant (CI) is currently the best option to partially restore hearing. This requires the 
auditory nerve to not be severely compromised or missing. In this rare case, implants need to stimulate 
structures more central to the auditory nerve, reducing hearing restoration outcome  compared to CIs 
(Peng et al., 2018). Most prominent example is the auditory brainstem implant (ABI), which can restore 
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a hearing percept, but speech perception is limited and the craniotomy is not without significant risk 
(Schwartz and Wilkinson, 2017). 
Electrical cochlear implants (eCI) consist of an internal part with an intracochlear electrode array 
encapsulated in silicone linked to an extracochlear stimulator. The stimulator is built of two parts: An 
implanted receiver connected to the electrodes in the cochlea and a speech processor including 
battery supply, microphones and a transmitter magnetically fixed on the skin. While the microphone 
picks up sounds from the environment, the acoustic signal is decomposed into frequency bands and 
transcutaneously transmitted to the receiver/stimulator delivering current pulses to the electrode 
contacts within the cochlea, directly stimulating the SGNs, thereby circumventing the non-functional 
sensory organ of Corti. Current flows from an active single electrode contact either to a reference 
electrode located in the temporalis muscle or in the housing of the receiver/stimulator in the so-called 
monopolar stimulation; or to a neighboring electrode, in the so-called bipolar stimulation. Thereby, 
the electrode array - located in the scala tympani - makes use of the tonotopic axis of the cochlea: a 
electrode contact located at the base primarily excites SGNs coding for high frequencies, while an 
electrode contact placed in the apex stimulates neurons coding for lower frequencies. Most implant 
systems make use of the monopolar configuration, as performance is at least comparable to bipolar 
stimulation (Zhu et al., 2012; Zwolan et al., 1996), but require far less battery power for auditory 
percepts (Pfingst and Xu, 2004) compared to the bipolar modality. 
Current CIs enable patients to comprehend open speech in quietness and to some degree in an 
environment with background noise, but the appreciation of music is limited (Kohlberg et al., 2014). 
Decisive for good speech comprehension is the amount of stimulation channels – in case of an eCI the 
number of electrodes. As reported by Shannon et al. (1995) speech recognition in quietness only 
requires 4 stimulation channels, whereas in noise 8 or more channels are necessary (Smith et al., 2002). 
For melody recognition Shannon et al. (Shannon et al., 2004) suggests to at least provide 48 spectral 
channels. While commercial CIs currently provide 12-24 physical channels, only a low number of 
effective channels can be used (Friesen et al., 2001) due to wide current spread within the highly 
conductive perilymph of scala tympani (Kral et al., 1998). This leads to broad activation of large 
subpopulations of SGNs resulting in reduced frequency resolution. If it comes to speech processing 
and coding strategy, the independent sites are limited to 4-8 (Fishman et al., 1997; Friesen et al., 2001; 
Garnham et al., 2002; Kiefer et al., 2000; Wilson, 1997). 
Another obstacle for CIs is the placement within the scala tympani: As the implant is commonly located 
close to the lateral wall of scala tympani, the large distance between stimulation site and SGNs in the 
Rosenthal’s canal further decreases performance for eCIs (Cohen et al., 2006). Furthermore, CIs barely 
cover the whole length of scala tympani (Lee et al., 2010; Wilson, 2008) due to its coiled structure and 
decrease in diameter (chapter 3). 
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Optical stimulation promises to bypass the bottleneck of current eCIs: Light can be spatially confined 
and does not lead to channel cross-talk (Figure 3, also see reviews (Dombrowski et al., 2018; Jeschke 
and Moser, 2015; Richter and Tan, 2014)). However, optogenetic stimulation requires genetic 
modification of the auditory nerve to render the cells sensitive for light stimulation. 
 
Figure 3. Schematic overview of different cochlear stimulation modalities 
Electrical cochlear implant (left) typically use 12-24 stimulation channels while for optical cochlear 
implants (middle) an increase of stimulation channels by an order of magnitude might be possible. The 
right panel shows fiber-based optical stimulation used for in vivo characterization in animal models. 
Modified and reprinted with permission from (Moser, 2015). 
1.3 Optogenetics 
Optogenetics enables selective control of target cells with light stimuli in space and time. The use of 
light-sensitive proteins to control cellular function is considered as one of the most revolutionary 
innovations in the life sciences in recent years. Channelrhodopsins (ChR) were discovered around the 
millennium in the green alga Chlamydomonas reinhardtii as a light-sensitive membrane protein used 
in phototaxy. The DNA sequence was identified in the Hegemann group as encoding for large microbial-
type rhodopsins. In collaboration with Nagel and Bamberg, expression and subsequent analysis in 
Xenopus oocytes of the two types ChR1 and ChR2 was achieved (Nagel et al., 2002, 2003). Several 
groups started working on these newly described blue light-gated ion-channels offering the possibility 
to manipulate cells electrically. In 2005, ChR2 was used to drive neural activity with a millisecond 
precision in hippocampal neuron cultures (Boyden et al., 2005). Shortly after, first in vivo studies 
demonstrated neural photostimulation with ChR2 in freely moving mice (Adamantidis et al., 2007) 
using a lentiviral gene transfer. Depending on the choice of opsin, discussed in the next chapter, it is 
not only possible to excite, but also inhibit neural activity (Figure 4). 
This was the beginning of a new era. The two main features of optogenetic applications to 
neuroscience are (1) matching the dynamics of neuronal action potentials and synaptic currents and 




Figure 4. Principle of optogenetics in neuroscience 
Illustration of the stimulation principles of electrical and optogenetic stimulation modalities. 
Optogenetic stimulation allows cellular and projection specificity, which is not feasible for electrical 
stimulation. The example shows electrical stimulation (left) vs. blue channelrhodopsin excitation 
(middle) vs. yellow halorhodopsin inhibition (right). Reprinted with permission from (Deisseroth, 
2011). 
1.3.1 Opsins 
The microbial optogenetic tools belong to the type I opsins and are found in all three domains of life: 
Archaea, bacteria and eukaryota. Type II opsins (animal type) are only found in higher eukaryotes 
responsible for vision or the circadian rhythm (Shichida and Yamashita, 2003). Both superfamilies 
belong to the seven-transmembrane proteins (Yizhar et al., 2011a). Here, we focus on the type I opsin 
family that are the main tools in optogenetics. Next to the light-sensitive ion channels, the 
bacteriorhodopsins (BR) and halorhodopsins (HR) compose the group of light-gated ion pumps (Figure 
5). While ChRs are selective for cations and BRs are outward proton pumps, HRs are light-activated 
chloride pumps, thus, - in neurons - the first two lead to excitation, while the latter lead to inactivation 
of the target cell (Figure 4). Recently, a light-driven inward proton pump was described (Inoue et al., 
2016) which enables further optogenetic control of cells. This thesis focuses on ChRs as it is most 
relevant for optogenetics in SGNs. 
 
Figure 5. Schematic of basic function of rhodopsins 
Light-gated cation channel channelrhodopsin (ChR, blue), chlorid pump 
halorhodopsin (HR, yellow) and outward proton pump bacteriorhodopsin (BR, 
turquoise). Modified and reprinted with permission from (Yizhar et al., 2011b) 
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For the light-gated ion channel to function it requires a retinal molecule which is a vitamin A-related 
organic cofactor assisting as the photon detector. In conjunction with the protein complex the retinal 
is termed rhodopsin. In channelrhodopsin, the most prominent optogenetic tool, the light-dependent 
ion channel undergoes several molecular transitions , which are described by several state maps based 
on spectroscopic methods (Bamann et al., 2008; Ernst et al., 2008; Neumann-Verhoefen et al., 2013; 
Ritter et al., 2008). Upon light stimulation, the molecule is thought to cycle through these states. In 
brief, the retinal absorbs photons leading to a series of conformational changes. The 
photoisomerization happens within nanoseconds, leading to an opening of the internal gate within 
sub-millisecond scale (τon), thus, enabling cations to pass through the pore (Kuhne et al., 2015). After 
light stimulation, the channel remains open - completing the photocycle - the so-called off-kinetics 
(τoff). The time interval after light-off varies greatly among ChRs. ChR2 – best activated at a wavelength 
of around 460 nm (Nagel et al., 2003) - has a τoff of about 10 ms (Gunaydin et al., 2010) which limits 
the temporal fidelity for high stimulation rates. Mutations in pore residues shortens the τoff  as in E123T 
(ChETA variant) to about 4 ms allowing sustained spiking of up to 200 Hz (Gunaydin et al., 2010). 
However, the increase in temporal fidelity comes at the cost of a decrease in light sensitivity since 
fewer channels remain in the open state on the photocurrent (Yizhar et al., 2011b). Another promising 
mutation, despite the slow τoff of 16 ms, is the calcium translocating ChR (CatCh). CatCh supports rapid 
repolarization due to enhanced calcium influx speeding up hyperpolarization and has an increased light 
sensitivity of about 70-fold (Kleinlogel et al., 2011). Chronos, a recently described channelrhodopsin 
isolated from Stigeoclonium helveticum (Klapoetke et al., 2014) promises to unite high light sensitivity 
and fast kinetics which will be discussed in chapter 2. 
Also, ChRs with different spectral properties are available: The first discovered ChRs best activated at 
a wavelength of around 530 nm is Volvox carteri ChR1 (VChR1) (Zhang et al., 2008). Soon modified 
variants like ReaChR and C1V1 were designed (Lin et al., 2013; Prigge et al., 2012; Yizhar et al., 2011c). 
More recently, the most red-shifted ChR to date – namely Chrimson - was identified in Chlamydomonas 
noctigama with an absorption peak at 590 nm (Klapoetke et al., 2014). Following Chrimson, two faster 
variants were engineered in the Bamberg lab (Mager et al., 2018): f-Chrimson and vf-Chrimson show 
channel kinetics close to Chronos. Red-shifted optogenetics offers advantages given the longer 
stimulation wavelength: higher transmission in organic tissue, thus allowing deeper tissue penetration 
and no phototoxic side-effects described for blue light stimulation.  An overview of the increasing 





Figure 6. Opsin kinetics and peak absorption wavelength for 
common optogenetic tool variants 
Data were recorded in neurons at room temperature except 
for *CatCh which was tested in HEK cells. Modified from 
(Jeschke and Moser, 2015; Yizhar et al., 2011b). 
1.3.2 Genetic modification 
Neurons need to be rendered sensitive to light by expression of opsins. This is achieved via genetic 
modification of the target neurons – the spiral ganglion neurons for the sake of this thesis. For basic 
research, transgenic lines are readily available for mice (Zeng and Madisen, 2012) and rats (Witten et 
al., 2011). For experiments in chapter 4, we used ChR2-expressing rats, in which ChR2 expression is 
driven by the broad neuronal promoter Thy1.2. However, for higher flexibility regarding the use of 
alternative opsins and later clinical translation to humans, the need for alternative genetic 
modification arises. 
Here the most promising approach considered today is gene transfer via viral vectors. This method 
allows easy and fast incorporation of newly designed components. Further, tissue and cell specificity 
can be regulated by the choice of promoter, capsid of specific viral subtypes, and application site. 
Adeno-associated viruses (AAVs) seem to be the best candidate to date as researchers for vision 
restoration were successfully running clinic trials to replace the gene RPE65 (reviewed in (Dalkara et 
al., 2016)). 
AAVs provide a number of advantages: (1) AAVs are not linked to any known cause of disease to date, 
(2) show low immune responses and (3) are replication-deficient. AAVs are able to integrate into the 
host genome at a safe harbor, however, common modifications on the AAV backbone restrict 
integration to form episomal DNA structures allowing long-term expression in post-mitotic cells. AAVs 
can effectively target different cell types across the cochlea (Shu et al., 2016) and were successfully 
used to deliver ChRs to the SGNs (Duarte et al., 2018; Hernandez et al., 2014; Mager et al., 2018). 
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1.3.3 Optical stimulators 
To be able to stimulate SGNs with light, an appropriate emitter needs to be placed in the coiled 
cochlea. The choice of emitter needs to be deliberately weighed against pros and cons of the respective 
optoelectronic device. This topic is covered in chapter 3 and 4. An overview of available optical 
stimulators is provided here. 
In principle, the emitter needs to be power-efficient, small enough to fit in the cochlea providing more 
stimulation channels than currently used for eCIs and bright enough to drive optically evoked action 
potentials in the light sensitive neurons. An oCI can be designed either as an active stimulator – 
generating light at the emitter site – or as an passive stimulator with waveguides transporting photons 
from an external light source to the target site of excitation. 
Light-emitting diodes (LEDs) promise to be an ideal candidate for an active oCI: Wafer-level processed 
LEDs based on gallium nitride (GaN) achieve power efficiencies of more than 50 % (Laubsch et al., 2010) 
and can be miniaturized to fit more than 100 emitters within the size of a mouse cochlea (Goßler et 
al., 2014). Next to conventional LEDs, organic LEDs (OLEDs) might provide an alternative promising 
high spatial resolution and mechanical flexibility at dimensions below cellular size (Steude et al., 2016). 
Passive oCIs, however, offer several advantages and have been similarly miniaturized to accommodate 
to the cochlear space (Schwaerzle et al., 2016a): The light generating element is located outside the 
spatially confined cochlea thus providing additional space. Further, potential heat is not presented to 
the sensitive inner ear. On the downside, coupling of light into waveguides comes with transmission 
loss (Cho et al., 2010; Zorzos et al., 2010). 
1.4 Outline 
This thesis aims at providing basic insight for optogenetic cochlear stimulation by addressing the 
following points also relevant for future translation: 
 Characterization of the most promising blue-light sensitive channelrhodopsins in the auditory 
system to estimate its potential for optogenetic research and hearing restoration 
 Evaluation of cochlear space across animal models commonly used in auditory neuroscience 
 Assessment of first multi-channel optical cochlear implant stimulation in the rat cochlea 
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2.1 Abstract 
Optogenetic tools, providing non-invasive control over selected cells, have the potential to 
revolutionize sensory prostheses for humans. Optogenetic stimulation of spiral ganglion neurons 
(SGNs) in the ear provides a future alternative to electrical stimulation used in cochlear implants. 
However, most channelrhodopsins do not support the high temporal fidelity pertinent to auditory 
coding because they require milliseconds to close after light-off. Here, we biophysically characterized 
the fast channelrhodopsin Chronos and revealed a deactivation time constant of less than a millisecond 
at body temperature. In order to enhance neural expression, we improved its trafficking to the plasma 
membrane (Chronos-ES/TS). Following efficient transduction of SGNs using early postnatal injection of 
the adeno-associated virus AAV-PHP.B into the mouse cochlea, fiber-based optical stimulation elicited 
optical auditory brainstem responses (oABR) with minimal latencies of 1 ms, thresholds of 5 µJ and 
100 µs per pulse, and sizable amplitudes even at 1000 Hz of stimulation. Recordings from single SGNs 
demonstrated good temporal precision of light-evoked spiking. In conclusion, efficient virus-mediated 
expression of targeting-optimized Chronos-ES/TS achieves ultrafast optogenetic control of neurons. 
2.2 Introduction 
Since the discovery of channelrhodopsins (ChRs, (Nagel et al, 2002, 2003) and the application of these 
light-gated ion channels for controlling excitable cells (Boyden et al, 2005), the concept of optogenetics 
has revolutionized the life sciences (Adamantidis et al, 2015; Kim et al, 2017). Application of 
optogenetics to restore sensory function in the immune-privileged eye and the ear are thought to have 
a fair chance of clinical translation (Jeschke & Moser, 2015; Sahel & Roska, 2013). Indeed, AAV-
mediated optogenetics for vision restoration has recently entered a first clinical trial in a dose-finding 
effort (RST-001 Phase I/II Trial for Advanced Retinitis Pigmentosa - Full Text View - ClinicalTrials.gov). 
While neural coding of visual information can likely be achieved with ChRs that deactivate within 
several milliseconds (Busskamp et al, 2012), faster ChRs are required for sound coding in spiral ganglion 
neurons of the ear (SGNs) that spike at hundreds of Hz with sub-millisecond precision (Jeschke & 
Moser, 2015).  
If such ultrafast optogenetic control of neural activity was available, it would serve auditory research 
and could fuel the development of future optical cochlear implants (oCIs). Clinically, this is highly 
relevant as approximately 360 million people – 5 % of the world’s population – suffer from a disabling 
hearing impairment (WHO, 2006) and we are still lacking causal therapies for the most common form; 
sensorineural hearing impairment. Consequences are impaired communication, often social isolation, 
depression, and reduction in professional capabilities. As of today, partial restoration of auditory 
function by hearing aids and electrical CIs (eCI) represent the options of choice for rehabilitation in 
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sensorineural hearing impairment, which results from cochlear dysfunction or degeneration. The eCI 
bypasses dysfunctional or lost cochlear hair cells via direct electric stimulation of SGNs and, with most 
of the approximately 500.000 users achieving open speech comprehension, is considered the most 
successful neuroprosthesis (Zeng, 2017; Lenarz, 2018). Nonetheless, there is an urgent need for further 
improvement of the CI. The biggest bottleneck of the eCI is the poor spectral resolution of coding that 
arises from the wide spread of current around each electrode contact (Kral et al, 1998). Using light for 
stimulation in oCI is one of the present developments to improve spectral coding by CIs, as light can 
be better spatially confined than electric current (e.g. Richter et al, 2011; Hernandez et al, 2014). One 
of the implementations used optogenetic stimulation of SGNs for a first proof-of-principle study on 
activation of the auditory pathway up to the midbrain (inferior colliculus, IC), demonstrating a lower 
spread of cochlear excitation for fiber-based oCI than for monopolar eCI (Hernandez et al, 2014). 
However, the temporal fidelity of ChR2-mediated optogenetic control of SGN firing seemed limited; 
auditory brainstem responses broke down even below 100 Hz of stimulation. Higher temporal fidelity 
of optogenetic SGN stimulation might be achieved when using faster ChRs such as Chronos (Klapoetke 
et al, 2014) or the newly engineered Chronos mutant ChroME (Mardinly et al, 2018).  
Therefore, characterizing and optimizing fast ChRs is of great importance for fast spiking neurons in 
the auditory system, but also in the somatosensory system, cerebellum, and a wide range of inhibitory 
circuits. Here, we targeted Chronos, the fastest ChR reported so far, and first dissected its gating by 
patch-clamp recordings of photocurrents. Towards its application for optogenetic stimulation of 
mouse SGNs we optimized Chronos, the viral vector and virus injection approach for achieving high 
plasma membrane expression. As described for another opsin (Gradinaru et al, 2010) we appended 
sequences for improved exit from the endoplasmic reticulum (ES) (Stockklausner et al, 2001; Ma et al, 
2001) and trafficking to the plasma membrane (TS) (Hofherr, 2005) to Chronos (Chronos-ES/TS) and 
performed postnatal injections of AAV-PHP.B serotype (Deverman et al, 2016), which drove highly 
efficient Chronos-ES/TS expression. We demonstrate by recordings of oABR and single SGN firing that 
Chronos-ES/TS enables ultrafast stimulation of the auditory pathway. 
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2.3 Results 
2.3.1 Chronos undergoes sub-millisecond on/off transitions at 36°C 
The kinetic properties of ChRs are best studied in cells with little background conductance to 
characterize the light-induced conductance in isolation. To this end, we used Human Embryonic Kidney 
cells 293T (HEK-293T cells) expressing Chronos or ChR2 (Methods). We clamped the membrane voltage 
to -60 mV where any light-induced change in the conductance is then linearly reflected in a change of 
the pipette current. First, we compared gating kinetics of ChR2 and Chronos at a low light intensity of 
0.27 mW mm-², far below the half maximal activation. At 22°C, we found activation and de-activation 
time constants (mean ± SEM) of act = 4.9 ± 0.3 ms, deact = 9.4 ± 1.0 ms (n = 6) for ChR2 and 
act = 1.5 ± 0.1 ms, deact = 3.0 ± 0.2 ms (n = 21) for Chronos (Figure 1A). When increasing the 
temperature to 36°C, activation and deactivation accelerated, with act = 0.58 ± 0.02 ms and 
deact = 0.76 ± 0.05 ms (n = 6), Chronos reached the sub-millisecond range, while ChR2 gating kinetics, 
act = 2.3± 0.1 ms, deact = 3.0 ± 0.3 ms (n = 6 and 5 respectively), at 36°C were comparable to the values 
achieved by Chronos at 22°C. Hence, already at such a low light intensity, Chronos, but not ChR2, 
activation and deactivation should permit signal transmission with a bandwidth of several hundred 
Hertz. Probing the frequency bandwidth directly by applying light chirps, Chronos confers a much 
higher bandwidth compared to ChR2 (Figure 1B). The gain of chirp responses could be very well 
characterized by a single cut-off frequency of 24 Hz and 86 Hz for ChR2 and Chronos, respectively, at 
22°C and 63 Hz and 150 Hz at 36°C (Figure 1C). 
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Figure 1. Chronos mediates fast light-driven currents 
(A) One second long light pulses (LED centered 480 nm, 0.27 mW mm-²) elicit current responses in HEK-
293T cells expressing ChR2 and Chronos, tested at 22°C and 36°C. Right panels show activation and 
deactivation at higher time resolution.  
(B) A quasi-periodic chirp stimulus is use to directly probe the bandwidth of Chronos- and ChR2-
mediated photocurrents in HEK-293T cells. Top: stimulus, middle: full response, bottom: sections from 
the beginning, middle and end of the response. Note the substantially larger frequency range over 
which Chronos currents follow the light stimulus. At 36°C this range is extended even further. 
(C) Analysis of the chirp responses of HEK-293T cells as in Figure 1B. The current amplitude modulation 
is plotted against the stimulus frequency. The smooth lines represent fits to the magnitude of the 
transfer function of a single pole filter 𝑎𝑏𝑠((1 + 𝑖𝑓/𝑓𝑐𝑢𝑡)
−1 ). 
2.3.2 Improving the plasma membrane expression of Chronos 
The above biophysical characterization had indicated Chronos as a strong candidate for optogenetic 
stimulation of SGNs with the required high temporal fidelity, provided sufficient plasma membrane 
expression can be achieved. Recent studies have shown that adding ER export and trafficking signals, 
isolated from a vertebrate inward rectifier potassium channel, to the cytoplasmic C-terminus of opsins 
promote their plasma membrane expression (Gradinaru et al, 2010). Hence, we added these 
sequences, here nick-named ES (Export Signal) and TS (Trafficking Signal), sandwiching EYFP, to 
Chronos (Chronos-ES/TS, Figure 2A). We first compared expression of Chronos-ES/TS and Chronos in 
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HEK-293T cells transfected with the respective pAAV plasmid by immunocytochemistry. Using confocal 
and stimulated emission depletion (STED) microscopy we found a preferentially peripheral, likely 
plasmalemmal, localization of Chronos-ES/TS with some intracellular signal most likely arising from the 
Golgi, while the original Chronos construct was more diffusely distributed throughout the extra-
nuclear intracellular space (Figure 2B-D). We quantified the cellular distribution of the opsin by line 
profile analysis (Figure 2C) and found a significantly greater peripheral than central 
immunofluorescence for Chronos-ES/TS when compared to the original Chronos construct (Figure 2C, 
D). The larger variance of the ratio of membrane and intracellular fluorescence for Chronos-ES/TS 
(Figure 2D) is likely explained by dividing by the relatively low, yet varying intracellular abundance of 
the opsin. In summary, the data suggests improved trafficking to the plasma membrane of Chronos-
ES/TS. 
 
Figure 2. Optimizing membrane expression of Chronos by adding ER-exit and trafficking signals: HEK-
293T cells 
(A) pAAV vector used in the study Chronos with a trafficking signal (TS), EYFP and ER export signal (ES) 
Chronos-ES/TS (upper) or containing the original Chronos-EGFP (Klapoetke et al, 2014), lower). In each, 
expression was driven by the human synapsin promoter (hSyn) and enhanced by the Woodchuck 
hepatitis virus posttranslational regulatory element (WPRE) and bovine Growth Hormone (bGH) 
polyadenylation signal (bGH poly A) sequences. ITR: inverted terminal repeats  
(B) Confocal and STED section of representative HEK-293T cells transfected with ChronosES/TS (upper) 
and Chronos (lower) and immunolabeled for FP: membranous labeling is more obvious for Chronos-
ES/TS. Scale bars: 10, 5 and 2 µm for left, middle and right panels. 
(C) Peak-normalized line profiles (7.5 µm) centered on the estimated membrane of HEK-293T cells 
expressing Chronos-ES/TS (blue) or Chronos (green) as in (B): mean ± SEM. Chronos-ES/TS-expressing 
cells showed a clear peripheral, likely membrane peak, which is missing in Chronos-expressing cells. 
Right panels show exemplary line profile placements (yellow). One line per cell was placed 
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perpendicular and centered to cell edge, aiming at sufficient intracellular coverage and avoiding 
fluorescent aggregates (arrowheads). N corresponds to analyzed cells (1 sample/cell). 
(D) Box and whisker plot ratio of maximal membrane and maximal cytoplasmic fluorescence of 
immunolabeled HEK-293T cells expressing Chronos-ES/TS or Chronos: Mann-Whitney U test showed 
significantly higher ratio in Chronos-ES/TS cells demonstrating an improved membrane expression of 
Chronos-ES/TS (p-value = 4.4e-4). The horizontal line within the box indicates the median, boundaries 
of the box indicate the 0.25- and 0.75-percentile, and the whiskers indicate the highest and lowest 
values of the results. Squares: individual data points. For details on membranous and cytoplasmic area 
see method section. 
Similar findings were also obtained in hippocampal neurons in culture transduced by AAV2/6 or AAV-
PHP.B (Figure 3). This indicates that neurons, too, struggle to traffic Chronos to the plasma membrane 
and that this can be alleviated when adding the ES- and TS-signals, at least when tested in culture. 
 
Figure 3. Improved membrane expression of optimized Chronos-ES/TS in hippocampal neurons 
(A) Hippocampal neurons infected at DIV 10 with two different versions of Chronos show very distinct 
expression patterns. Neurons infected with Chronos-ES/TS (upper panels) either using AAV2/6 (left) or 
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PHP.B virus (middle) show very specific plasma membrane expression in somatic regions and proximal 
dendrites. Infection of neurons with Chronos (lower panels) either using AAV2/6 (left) or AAV-PHP.B 
(middle) showed more intracellular opsin abundance. Right panels show exemplary line profile 
placement (yellow). Scale bar: 50 µm applies to all panels. 
(B) Peak-normalized line profiles (1.5 µm) centered on the outer cell edge of AAV-PHP.B transduced 
hippocampal proximal dendrites expressing Chronos-ES/TS (blue) or Chronos (green) as in (A): mean ± 
SEM. Chronos-ES/TS-expressing cells showed a clear peripheral, likely plasmalemmal peak, which is 
missing in Chronos-expressing cells. 
(C) Box and whisker plot of the ratio of maximal membrane and maximal intracellular fluorescence of 
immunolabeled hippocampal neurons expressing Chronos-ES/TS or Chronos: Mann-Whitney U test 
showed significantly higher ratio in Chronos-ES/TS cells demonstrating an improved membrane 
expression of Chronos-ES/TS (p-value = 4.2e-8). The horizontal line within the box indicates the 
median, boundaries of the box indicate the 0.25- and 0.75-percentile, and the whiskers indicate the 
highest and lowest values of the results. Squares: individual data points. For details on membranous 
and cytoplasmic area see method section. 
2.3.3 AAV-mediated expression of Chronos and Chronos-ES/TS in mouse SGNs 
Next, we turned to expression of Chronos in mouse SGNs in vivo and, once more, compared the original 
Chronos and Chronos-ES/TS. We aimed to establish efficient AAV-mediated transduction of SGNs and 
employed the human synapsin promoter (hSyn, Figure 2A) that had turned out to drive efficient and 
specific SGN expression (Hernandez et al., 2014). We first followed our previous protocol using 
transuterine injections of AAV2/6 into the otocyst of mouse embryos at embryonic day 11.5 (Figure 
4A, upper). In most of the cases the expression of Chronos-EGFP was absent or sparse (Figure 4B, left 
and middle). Exceptionally we saw high expression levels (Figure 4B right). As before (Hernandez et al., 
2014), the expression, if any, was largely limited to the SGNs of the basal cochlear turn and was never 
seen in inner hair cells (Figure 4B right, inset). 
Next, we moved on to early postnatal injections (Figure 4A, middle and lower, postnatal day 5-7) into 
the cochlea via the round window, which had proven highly successful for transduction of hair cells 
(e.g. Akil et al., 2012; Jung et al., 2015). We employed AAV-PHP.B, a novel AAV-serotype (Deverman et 
al, 2016) with improved efficiency of neural transduction, for expression of Chronos-ES/TS and Chronos 
(hSyn promoter, comparable titers, 1012 GC ml-1) in SGNs. 12 out 12 AAV-PHP.B-injected mice showed 
substantial SGN transduction in immunohistochemistry for Chronos-ES/TS and 9 out 9 for Chronos. 
Postnatal injection of AAV-PHP.B drove strong expression of Chronos-ES/TS across all cochlear turns 
(Figure 4C). Similar to HEK-293T cells and hippocampal neurons in vitro, Chronos-ES/TS localized 
preferentially peripheral, likely plasmalemmal in SGNs in vivo, while the original Chronos construct was 
more diffusely distributed throughout the cell (Figure 4D). Once again, we quantified the cellular 
distribution of the opsin by line profile analysis (Figure 4E) and found a significantly greater peripheral 
than central immunofluorescence for Chronos-ES/TS when compared to the original Chronos construct 
(Figure 4E, p = 4.1e-5). The difference can be appreciated by the 0.56 µm more intracellular 50 % FP-
immunofluorescence for Chronos. We note that the cytosolic parvalbumin immunofluorescence 
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allowed a better estimation of the cell border which was independent of the opsin expression, both 
advantageous when compared to HEK-293T cell analysis (Figure 2). Despite some differences in 
absolute numbers between both analyses, which are not unexpected given the different cell types, 
means of transfection and analysis method, both support the main observation: improved relative 
plasma membrane abundance of Chronos-ES/TS. 
 
Figure 4. Establishing efficient expression of Chronos in SGNs: use of Chronos-ES/TS, potent AAV-
PHP.B, and postnatal mode of AAV-injection 
(A) Upper panel: schematic representation of the viral injection into the embryonic otocyst (left: black 
cylinder marks the light guide used to trans-illuminate the embryo in the uterus after mobilization from 
the abdominal cavity, green: micropipette filled with fast green-colored AAV suspension). Middle 
panel: schematic representation of AAV-injection into the postnatal cochlea via the round window 
(RW). Lower panel: surgical situs of a p7 mouse with retroauricular incision, graphical aid encircles the 
injection site). Inset shows ex-vivo cochlea just after AAV injection via RW. Scale bar: 2 mm. 
(B) Maximum projection of confocal images of immunolabeled mid-modiolar cochlear cryosections 
(exemplary sections of basal turn) of embryonically AAV2/6-Chronos-injected mice collected at 4-
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weeks of age. EYFP (green) marks transduced SGNs, calretinin (magenta) was used as generic marker 
of SGNs, scale bar: 50 µm. In the inset, color code for EYFP channel was changed to fire (EYFP). Left 
panel: most common, non-expressing example, inset shows zoom of negative SGNs. Middle panel: 
occasional, sparsely expressing example, inset: one out of two positive SGNs. Right panel: rare, highly 
expressing example, inset: negative inner hair cell (calretinin in gray), exclusive localization of EYFP in 
the SGN boutons and fibers. 
(C) Postnatally AAV-PHP.B-Chronos-ES/TS-injected mouse (see (B) except where stated differently). 
EYFP (green) marks transduced SGNs, parvalbumin (magenta) was used as generic marker of SGNs, 
scale bar: 50 µm. High transduction rate, good membrane expression. In inset, color code for the green 
channel was changed to fire for better visualization. Similar to (B). 
(D) Postnatally AAV-PHP.B-Chronos-injected mouse (see (C) except where stated differently). 
Substantial SGN transduction, poor membrane expression. 
(E) Line profile analysis of FP-immunofluorescence across the membrane of SGN somata. Traces were 
centered at the transition from high to low parvalbumin immunofluorescence as a proxy of plasma 
membrane location. Left panel: clear membrane abundance in Chronos-ES/TS (blue, mean ± SEM), but 
mostly intracellular localization in Chronos (green, mean ± SEM). Right panel: Box and whisker plot of 
the ratio of maximal membrane and maximal intracellular FP fluorescence for Chronos-ES/TS (left) and 
Chronos (right): stronger relative membrane expression in Chronos-ES/TS (Mann–Whitney U test, p-
value = 4.1e-5). Squares: individual data points. For details on membranous and cytoplasmic area see 
method section. 
(F) Box and whisker plot of the fraction of FP-positive SGNs (transduced out of all parvalbumin-positive 
SGNs) for the apical, middle and basal cochlear turn of the injected ear (colored) and contralateral, 
non-injected (grey) ear of Chronos-ES/TS-AAV-PHP.B and Chronos-AAV-PHP.B mice. Points: individual 
animals plotted on top; n refers to number of cochleae studied. The horizontal line within the box 
indicates the median, boundaries of the box indicate the 0.25- and 0.75-percentile, and the whiskers 
indicate the highest and lowest values of the results. 
(G) Box and whisker of the SGN density for the apical, middle and basal cochlear turn of the injected 
(colored) ear and the contralateral, non-injected (grey) ear (as in (F)). No significant differences 
between Chronos and Chronos-ES/TS nor between injected and non-injected ear. Points: individual 
animals plotted on top; n refers to number of cochleae studied. 
When analyzing the transduction rates in the injected (left) and non-injected (right) cochleae, we 
confirmed robust SGN transduction across all turns of the injected cochlea for both Chronos-ES/TS and 
Chronos (Figure 4F). We note that the counterstain for parvalbumin- used for AAV-PHP.B injected 
ears, is a more general marker of SGNs than calretinin, used for AAV2/6 injected ears, which is present 
only in a subset of SGNs. Therefore, if anything, we would have been prone to overestimate the 
transduction rate for AAV2/6 injected ears, which, however, was very low. Interestingly, for both cases 
of AAV-PHP.B injection we also found substantial expression in the contralateral, non-injected 
cochleae, indicating spread of virus in the specific conditions of pressure injection into the scala 
tympani of the early postnatal cochlea. This spread likely occurred via the cochlear aqueduct and/or 
the endolymphatic ducts and the cerebrospinal fluid space (Lalwani et al, 1996). The density of SGNs 
in the injected as well as in non-injected ears were comparable (Figure 4G). The injected mice behaved 
normal as concluded from routine animal observation.  
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2.3.4 Chronos-mediated optogenetic neural stimulation of the auditory pathway: transuterine 
injections of AAV2/6 
We performed acute recordings of oABRs using fiber-coupled laser stimulation 4-12 weeks after AAV-
injection. Following posterior tympanotomy, we inserted a 50 µm optical fiber through the round 
window (RW) to project the light of a blue laser (λ = 473 nm) onto the SGNs. When oABRs were present 
(Figure EV1), we typically found three to five oABR peaks, which likely reflected the synchronous 
activation of Chronos-expressing SGNs (first peak) and downstream auditory pathway (subsequent 
peaks). Transuterine injections of AAV2/6-Chronos did not generally support oABRs; only 3 out of 120 
injected mice (including 2 different AAV2/6 produces) showed oABRs. In these positive mice, oABR 
grew in amplitude and showed shorter latencies when increasing radiant flux (see inset of Figure EV1). 
 
Figure EV1. Demonstrating functional expression of Chronos in SGNs following transuterine AAV2/6 
injection reported by recordings of oABRs 
In 3 out of 120 animals we could record oABRs using fiber-coupled laser stimulation 4-12 weeks after 
embryonic transuterine injection of AAV2/6 carrying Chronos using 4 ms pulses at 10 Hz with 30 mW 
radiant flux. Responses were verified as oABRs by the increasing amplitude with stronger light pulses 
(inset: shows oABRs of an exemplary oABR-positive mouse for varying radiant flux, colors code the 
radiant flux in mW). A small onset and offset artifact (arrowheads) is visible for the average (black) of 
the negative animals (gray, n = 117) which we occasionally observed in the early phase of the project. 
2.3.5 Chronos-ES/TS enables ultrafast optogenetic stimulation of the auditory pathway: oABRs 
Postnatal injection of AAV-PHP.B reliably achieved high transduction rates (Figure 4), which enabled 
oABRs in 19 out of 20 AAV-PHP.B-Chronos-ES/TS-injected mice and 8 out of 17 AAV-PHP.B-Chronos-
injected mice. Next, we performed a detailed characterization of Chronos-ES/TS-mediated optogenetic 
activation using oABRs and compared the results to those obtained with Chronos. oABR amplitude 
grew with increasing stimulus intensity (Figure 5A, B, 1 ms light pulses delivered at 10 Hz – averaged 
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across 1000 repetitions), while oABR latency (i.e. the time interval between the stimulus onset and the 
oABR P1 wave) got shorter for Chronos-ES/TS (sign test between the threshold and highest radiant flux 
tested, p-value = 0.009) and was constant for Chronos (Figure 5A, C; p-value = 0.11). oABR thresholds 
and amplitudes differed between animals (shown for the first peak, P1-N1, Figure 5B). Stimuli as weak 
as 1.08 mW (duration: 1 ms, rate: 10 Hz – averaged across 1000 repetitions) were sufficient to drive 
oABRs in one Chronos ES/TS injected mouse and 4.56 mW in a Chronos injected mouse. For 1 ms light 
pulses delivered at 10 Hz, the average oABR threshold amounted to 6.58 ± 1.08 mW and 
13.95 ± 3.52 mW for Chronos-ES/TS and Chronos, respectively (p-value = 0.0367, Mann–Whitney U 
test; n = 13 and n = 8). In most animals oABR amplitudes grew with radiant flux increasing over more 
than one order of magnitude (Figure 5B). The minimal latency of the first oABR peak (P1, Figure 5C) 
amounted to 0.95 ± 0.07 ms (n = 13) for Chronos-ES/TS and 1.26 ± 0.07 ms for Chronos (n = 8, p-
value = 0.014, Mann-Whitney U test). 
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Figure 5. Characterizing optogenetic stimulation by recordings of oABRs 
(A) oABRs driven with varying radiant flux (1 ms at 10 Hz, colors code the radiant flux in mW) for 
exemplary mice injected with AAV-PHP.B-Chronos (left) or AAV-PHP.B-Chronos-ES/TS (right).  
(B) Normalized P1 – N1 amplitude of oABR as a function of light intensity for Chronos as in A (green, 
throughout figure) and Chronos-ES/TS (blue). Radiant flux was binned per 5 mW steps (horizontal 
error: ± SEM). Inset: maximal absolute P1 – N1 amplitude of oABR (mean ± SEM) was greater for 
Chronos-ES/TS than for Chronos (Mann–Whitney U test, p-value ≤ 0.001). 
(C) Latency of oABR P1 as a function of radiant flux as in (B). Radiant flux was binned per 5 mW steps 
(horizontal error: ± SEM). 
(D) oABRs driven with varying stimulus duration (10 Hz, 38 mW, colors code the duration) for 
exemplary mice injected with AAV-PHP.B-Chronos (left) or AAV-PHP.B-Chronos-ES/TS (right). 
(E) P1-N1 amplitude as a function of stimulus duration as in (D) (normalized against the largest P1-N1 
oABR amplitude). 
(F) Latency of oABR P1 as a function of stimulus duration as in (E). 
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(G) oABRs driven with varying stimulus rate (1 ms and 0.5 ms for 10-500 Hz and 500-1000 Hz, 
respectively, 38 mW, colors code the stimulus rate) for exemplary mice injected with AAV-PHP.B-
Chronos (left) or AAV-PHP.B-Chronos-ES/TS (right). 
(H) P1-N1 amplitude as a function of stimulus rate as in (G) (normalized against P1-N1 oABR amplitude 
at 20 Hz). 
(I) Latency of oABR P1 as a function of stimulus rate as in (H): Chronos-ES/TS enables responses up to 
at least 1000 Hz. Dashed line indicates latencies data points obtained with a pulse duration of 0.5 ms. 
The P1-N1 amplitude and P1 latency were measured on the same animals. Animal count (n) is stated 
on bottom right of panel B, E and H. Data are expressed as mean ± SEM. 
oABRs could be elicited by light pulses as short as 20 µs with Chronos-ES/TS and 400 µs with Chronos 
(irradiance: 38 mW, rate: 10 Hz – averaged across 1000 repetitions, Figure 5D, E). oABR amplitudes 
grew with pulse duration up to approximately 0.6 ms and tended to become smaller for longer pulses, 
possibly due to accumulating channel inactivation and/or increasing depolarization-block of SGNs 
upon prolonged photo-depolarization (Figure 5D, E).  
Next, we tested the dependence of oABRs on the stimulus rate (duration: 1 ms up 500 Hz and 0.5 ms 
from 500 Hz, intensity: maximum (38-43 mW)). When increasing stimulus rate, oABR amplitudes 
declined (Figure 5G) and latencies prolonged (Figure 5G, I). However, in contrast to our previous 
reports on : i) ChR2: where potentials were found only up to 60 Hz (Hernandez et al, 2014); ii) CatCh: 
up to 200 Hz, and f-Chrimson: up to 250 Hz (respectively (Wrobel et al, 2018; Mager et al, 2018)); we 
could detect sizable P1-N1 up to stimulus rates of 500 Hz for Chronos (Figure 5G left, H) and 1000 Hz 
for Chronos-ES/TS (the highest stimulus rate tested in our experiments, Figure 5G-H). P1-latency 
increased with higher stimulus rates in both cases.  
2.3.6 Chronos-ES/TS enables ultrafast optogenetic stimulation of the auditory pathway: recordings 
from single putative SGNs 
To further validate the Chronos-ES/TS-mediated SGN stimulation and evaluate the temporal fidelity of 
stimulation, we performed juxtacellular recordings from auditory nerve fibers (central axon of SGN) as 
described in (Hernandez et al, 2014; Mager et al, 2018). In brief, we targeted glass micropipettes to 
where the auditory nerve enters the anteroventral cochlear nucleus (AVCN) and searched for 
responses while stimulating the SGNs through the round window via an optical fiber coupled to a blue 
laser. We favored recordings of SGNs by deep positioning (>1000 µm relative to the surface of the 
cochlear nucleus) of the pipette tip, but, given that responses to acoustic stimuli were lost upon the 
ear surgery, we could not safely discriminate SGNs from AVCN neurons, hence, we termed the light-
responsive neurons “putative SGN”. We found that the putative SGNs fired upon optogenetic 
stimulation with high temporal precision for stimulus rates of up to hundreds of Hz (Figure 6A, B); some 
neurons followed stimulation to some extent even up to 1000 Hz (Figure 6B). Temporal precision of 
firing, evaluated based on vector strength (Goldberg & Brown, 1969), see methods, Figure 6C) and 
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spike jitter (i.e., standard deviation of spike latency across trials, Figure 6D), was generally high, but 
varied across the recorded neurons. 
 
Figure 6. Characterizing optogenetic stimulation by extracellular recordings from single putative 
SGNs 
(A) Raster plots showing spiking activity from a representative putative SGN (“unit”) in response to 400 
ms-long trains of laser pulses (at 30 mW, 1 ms for 20-600 Hz, 500 µs for ≥700 Hz) recorded at five 
different stimulation rates over 20 repetitions. Polar plots to the right side of raster plots show 
synchronicity of firing relative to the cycle between two pulse onsets.  
(B) Same protocol and analysis of the “fastest unit” recorded, showing lower adaptation and firing even 
at very high stimulation rates. 
(C-F) Quantification of the vector strength (C), spike jitter (D), spike probability (E) and discharge rate 
(F) as a function of repetition rate of 40 putative SGNs (obtained from 6 mice). In panel D the red-
shaded area represents the hazard function obtained in response to simulated Poisson spike trains.  
Black data points and lines show mean ± SEM, individual units are shown in gray. The units shown on 
panels A-B are shown in green and blue, respectively. Number of units tested for each repetition rate: 
20 Hz: 40, 50 Hz: 25, 100 Hz: 24, 200 Hz: 26, 300 Hz: 21, 400 Hz: 20, 500 Hz: 21, 600 Hz: 18, 700 Hz: 18, 
800 Hz: 19, 900 Hz: 21, 1000 Hz: 19. 
Temporal precision and spike probability (Figure 6E) diminished with increasing stimulation rates, 
indicating that single SGNs code optogenetic information in a less reliable manner at very high 
stimulation rates. Spike jitter, calculated for spikes occurring in a time window comprised between 
two pulse onsets, increased with rate but was typically below a millisecond for stimulus rates lower 
than 300 Hz (Figure 6D). At higher stimulus rates, spike jitter increased beyond the values obtained for 
simulated Poisson spike trains (see methods, red-shaded area, Figure 6D), indicating spike 
synchronization with the light pulses became less reliable. The lower spike precision and limited spike 
probability at stimulus rates beyond 100 Hz observed are likely compensated by the population 
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response, as several SGNs jointly encode information from each place of the tonotopic map (Liberman, 
1978). 
Light-evoked firing rate patterns differed among the putative SGNs as stimulation rates increased 
(Figure 6F). There was, in general, a linear rise of discharge rates up to 100 Hz, followed by a constant 
decrease as a response to mid and high stimulation rates. Nevertheless, some putative SGNs were able 
to maintain moderate (and to some extent synchronized) spike rates even at pulse rates of 1000 Hz 
(fibers showing computable spike probability —see Methods— at 500 Hz: 7/21, 33.3%; at 600 Hz: 3/18, 
16.7%; at 700 Hz: 3/18, 16.7%; at 800 Hz: 1/19, 5.26%; at 900 Hz: 2/21, 9.52%; and at 1000 Hz 2/19, 
10.53%). Interestingly, the response patterns of the putative SGNs that we recorded varied across units 
at increasing stimulation rates (Figure EV2). We found two main types of responses; putative SGNs 
that rapidly adapted their spiking as stimulation rates rose (Figure EV2A), and neurons that continued 
spiking even at very high pulse rates (albeit with a lower frequency as compared to lower stimulation 
rates, Figure EV2B). 
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Figure EV2. Activity of two exemplary putative SGNs upon light stimulation at increasing repetition 
rates 
(A) Raster plot showing spike timing (blue symbols) of a rapidly adapting putative SGN in response to 
400 ms pulse trains at stimulation rates 50-1000 Hz (30 mW, 1 ms for 50-600 Hz; 30 mW, 0.5 ms for 
700-1000 Hz). 
(B) Raster plot showing activity of a slowly adapting putative SGN in response to the stimulation 
paradigm described in (A). 
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2.4 Discussion 
Here, we characterized and optimized Chronos for its utility in fast optogenetic control of excitable 
cells. We demonstrate sub-millisecond off-kinetics at physiological temperature of Chronos. Using the 
auditory system as a fast spiking neural model circuitry, we show that Chronos supports ultrafast 
control of neuronal spiking. In doing so, we solved a major shortcoming that plagued optogenetics as 
a stimulus modality for the cochlea; the low temporal fidelity of light-driven SGN-firing, caused by the 
slow deactivation kinetics of the ChR2 employed so far. We found that adding sequences promoting 
ER-exit and plasma membrane trafficking to Chronos (Chronos-ES/TS) and using postnatal injection of 
the powerful AAV-PHP.B vector critically improved the in vivo utility. In conclusion, Chronos-ES/TS in 
combination with potent viral vectors such as AAV-PHP.B is a promising tool for auditory neuroscience 
and a candidate ChR for use in future optical CIs. 
2.4.1 Biophysical characterization of Chronos and improving plasma membrane expression 
Here, we compared activation and deactivation for ChR2 and Chronos and also studied the 
temperature dependence of gating for Chronos. In our hands Chronos deactivates about 3 times faster 
than ChR2 and has sub-milliseconds off-kinetics at physiological temperature with a Q10 of 2.7. This 
reflects short-lived open states for Chronos resulting in lower open probability, which together with 
the relatively poor membrane expression likely explains the challenges we faced with using the original 
Chronos construct for driving SGN spiking, when using the transuterine injection in the AAV2/6-hSyn 
vector that we previously used successfully for the ChR2 mutant CatCh (Hernandez et al, 2014). No 
problems were reported in two other studies of Chronos in the auditory system using different viruses 
and stages of the pathway; cochlear nucleus (Hight et al, 2015) and inferior colliculus (Guo et al, 2015). 
A recent study using the in silico predicted ancient AAV Anc80 also achieve functional expression in 
the cochlea, but did not differentiate between expression in SGNs and hair cells (Duarte et al, 2018). 
Inspecting the Chronos-GFP expression in the cochlear nucleus (Figure 2 of (Hight et al, 2015)) and 
SGNs (Duarte et al, 2018) suggest a similar diffuse intracellular distribution as we observed in HEK-
293T cells (Figure 2) and hippocampal neurons (Figure 3) in culture as well as in SGNs in our study 
(Figure 4). Using these 3 cell types and vastly different conditions, we show a robust improvement of 
the plasma membrane expression of Chronos upon adding ER-export (Stockklausner et al, 2001; Ma et 
al, 2001) and trafficking signals (Hofherr et al, 2005) of inward rectifying K+ channels. Introduction of 
the powerful AAV-variant AAV-PHP.B (Deverman et al, 2016) was an additional factor changing the 
game: even the unmodified Chronos (Klapoetke et al, 2014) enabled oABRs on a regular basis. 
However, when comparing the functionality of Chronos-ES/TS with enhanced membrane trafficking to 
Chronos, transduced by the same AAV-PHP.B vector, titer, injection method and incubation time, we 
found increased oABR amplitudes and improved temporal fidelity of the Chronos-ES/TS-mediated 
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responses, when increasing the rate of stimulation. Disentangling the contributions of the improved 
membrane expression and the slightly higher fraction of Chronos-positive SGNs with Chronos-ES/TS is 
challenging. Regardless of the precise contributions, these experiments suggest that Chronos-ES/TS 
will be a valuable tool for optogenetic applications requiring good temporal fidelity. Moreover, 
avoiding the largely intracellular localization of Chronos lowers the proteostatic stress to the cell. 
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2.4.2 Ultrafast Chronos-mediated stimulation of the auditory pathway 
Stimulation of the auditory pathway is a prime example for an application of optogenetics requiring 
both high speed and light sensitivity. Upon sound stimulation, SGNs fire at hundreds of Hz and show 
sub-millisecond temporal precision of spiking relative to the stimulus. When considering optogenetics 
for improved cochlear prosthetics, each stimulus should not exceed the energy requirements of 
electrical cochlear implants which are in the range of 0.2 µJ per pulse (Zierhofer et al, 1995). However, 
so far, the threshold for optogenetic activation of SGNs reported for ChR2 and ChR2 variant CatCh 
amounted to approximately 2 µJ, and the responses broke down for stimulation rates exceeding 20 Hz 
(Hernandez et al, 2014).  
Chronos, featuring a sub-millisecond deactivation time constant at physiological temperature (Figure 
1) is an obvious candidate for cochlear optogenetics. So far, we had employed transuterine AAV2/6-
injections into the embryonic otocyst and observed a strong basoapical gradient of expression in the 
cochlea (Hernandez et al, 2014). Using AAV-PHP.B, a novel AAV vector (Deverman et al, 2016) at high 
titers (1-2.5 1012 GC/ml) for injections into the cochlea of p5-p7 mice, we found highly efficient 
transduction of SGNs across all cochlear turns (Figure 5). The light thresholds estimated for oABRs 
mediated by Chronos-ES/TS in SGNs following postnatal AAV-PHP.B injections the average oABR 
threshold amounted to approximately 7 µJ (14 µJ for Chronos), which is substantially higher than the 
energy per pulse employed for suprathreshold stimulation in eCIs. Therefore, further improvements 
of membrane expression of Chronos or the design of fast channels with larger pore remain an 
important objective. At present, we can only speculate how much light will be required for an auditory 
percept mediated by Chronos-based cochlear optogenetics. Future studies using behavioral 
experiments will be required to address this point. Nonetheless, we argue that future optogenetic CIs 
might not need the high stimulation rates employed in eCIs (800 Hz or higher) which might help 
balancing a greater energy requirement per pulse of an oCI. In most animals, oABR increased in 
amplitude when increasing light intensity over more than one order of magnitude (Figure 6). Hence, 
the output dynamic range of optical stimulation assessed as P1-N1 amplitude, on average, was > 20 dB 
compared to typically < 10 dB for coding with eCI (Zeng et al, 2008). This likely reflects the lower spread 
of excitation with optical stimulation as well as differences in the levels of Chronos-ES/TS expression 
among SGNs at the same tonotopic place of stimulation. 
The temporal fidelity of Chronos-ES/TS-mediated optogenetic stimulation was estimated at the single 
SGN and the SGN population levels. The minimal oABR latency was considerably shorter 
(1.01 ± 0.09 ms) than that of the first light-evoked potential, typically a trough, that we had previously 
reported for transgenic ChR2 mice (3.14 ± 0.26 ms (Hernandez et al, 2014)). Moreover, the minimal 
duration of the light pulse required for eliciting an oABR at high light intensity was shorter (<100 µs) 
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than that found before with ChR2 or CatCh (≥ 200 µs; (Hernandez et al, 2014)). Most importantly, 
population responses mediated by Chronos-ES/TS followed pulse rates up to at least 1000 Hz unlike 
for ChR2, where oABRs were lost below 100 Hz. Obviously, the analysis had to be restricted to a very 
short measurement time window in order to track the response to such high rates and hence signal 
propagation along the pathway cannot be demonstrated. This ABR analysis suggests that the Chronos-
ES/TS mediated optogenetic stimulation achieves a temporal fidelity similar to that of acoustic coding. 
Using juxtacellular recordings we could demonstrate firing of single SGNs in response to trains of light 
pulses at hundreds of Hz with sub-millisecond temporal precision. Such temporal fidelity of 
optogenetic control of SGN firing marks a major breakthrough on the way towards using optogenetic 
stimulation for auditory research and for the future development of the clinical optical cochlear 
implant. 
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2.5 Materials and Methods 
2.5.1 Illumination during patch clamp 
Illumination at 488 nm was provided either by a frequency doubled solid state laser (Sapphire, 
Coherent) or by a diode laser (Cobolt MLD). The solid state laser was shuttered by a custom made, 
mechanical shutter based on the voice-coil actuator of a hard drive (Maguire et al, 2004). The diode 
laser provided even faster on/off times and made it possible to rapidly change amplitudes. However, 
its output was not as stable as the solid state laser. Especially after drastic intensity changes, the 
intensity oscillated by up to 10%, which also led to oscillating Chronos currents. The beams of the lasers 
were coupled into the optical path of the microscope and focused on the sample to a spot size smaller 
than the field of view of the camera, to precisely determine the absolute intensity in the plane of the 
cells. The laser power was adjusted by neutral density filters, and the absolute power of the laser was 
measured at the position of the sample with a photo-diode based power-meter (PM100D, Thorlabs, 
Newton, NJ). A photo-diode recorded the temporal shape of the laser intensity during the experiments 
and digitization was performed by the patch-clamp amplifier also used for triggering the laser shutters 
(EPC10, HEKA, Lambrecht, Germany). The average intensity on each cell was calculated by comparing 
the size and exact position of the cell with the intensity profile of the laser spot. When using the 
mechanical shutter, artifacts lasting only two data-points were common during switching due to the 
strong transient currents in the voice-coil. These were removed in post processing. For the initial 
kinetic analysis a rapidly switchable 480 nm LED was placed 25 mm below the cells (5 W Luxeon rebel 
color with Lambertian dome, Philips Lumileds), that provided homogeneous whole-field illumination 
at a maximum of 0.27 mW/mm². 
2.5.2 Cloning 
For the cloning of pAAV_hSyn_Chronos-ES/TS as a starting material we have used pAAV-Ef1a-DIO-
eNpHR 3.0-EYFP (Addgene, plasmid nr. #26966). In order to obtain flanked EYFP with ES/TS sequences 
we perform a classical PCR reaction. The primers that we used for this cloning were 5’-
GAGAACCGGTCAAGAGCAGGATCAC-3’ and 5’-GTGGGGTACCCCTTACACCTCGTTCTC-3’. In the second 
step obtained PCR fragment was digested with AgeI/Acc65I (Thermo Scientific, MA, USA) (Acc65I 
produces compatible cohesive ends as BsrGI) gel extracted (GeneJET Gel Extraction Kit, Thermo 
Scientific, MA, USA) and further used for ligation. At the same time plasmid pAAV_hSyn_Chronos-GFP 
(Addgene, plasmid no. 59170) was also digested using restriction enzymes AgeI/BsrGI and used as a 
backbone plasmid. All obtained ligation products were further tested by the mean of colony PCR and 
finally sequenced by external company. 
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2.5.3 Cell Culture and HEK-293T transfection 
HEK-293T cells (ATCC, USA) were cultured at 37°C and 5 % CO2 in DMEM (Gibco, USA) supplemented 
with 10 % fetal calf serum (Gibco, Germany), and 1 % penicillin/streptomycin (Sigma, Germany). One 
day prior to transient transfections the HEK293T cells were seeded on 24-well plates. Day after cells 
were transiently transfected with pAAV_hSyn_Chronos-ES/TS or pAAV_hSyn_Chronos using PEI 
25.000MW (Polysciences Inc. USA). Two days after transfection cells were briefly washed and then 
fixed with 4 % PFA for 10 min. After fixation cells were mounted with Mowiol (Sigma, Germany) and 
processed to confocal/STED imaging. Cells were regularly tested for mycoplasma contamination. No 
method of cell line authentication was used. 
For characterization of gating kinetics, HEK-293T cells were transfected with 3-5 µg of plasmid DNA 
encoding a ChR2-YFP or a Chronos-GFP fusion protein via nucleofection using a Lonza nucleofector 
device and the Amaxa Cell Line Nucleofection Kit V (Lonza, Switzerland; program Q-01), following the 
manufacturer’s instructions. The pcDNA 3.1-ChR2-YFP construct was kindly provided by Ernst Bamberg 
(MPI for Biophysics, Frankfurt, Germany), and Chronos-GFP was kindly provided by Edward Boyden 
(MIT, Cambridge, MA). After transfection, the cells were plated on poly-L-lysine coated 10 mm glass 
cover slips. Electrophysiological characterization was performed 20 to 30 h after transfection. 
2.5.4 Electrophysiology 
Transfection success was accessed via fluorescence in an inverted Axiovert 135 TV fluorescence 
microscope (ZEISS, Germany), equipped with a 40X/0.65 N.A. Achroplan objective. Only cells isolated 
from others and exhibiting clear membrane fluorescence signal were recorded. Whole-cell patch-
clamp recordings were made in voltage-clamp mode (-60 mV holding potential) in an EPC 10 USB 
amplifier (HEKA Elektronik, Germany). Current signals were low-pass filtered at 3 kHz and digitized at 
20 kHz. Patch-pipettes were prepared from PG10165-4 glass capillaries (World Precision Instruments, 
USA) in a PIP 6 vertical puller (HEKA Elektronik, Germany), and had resistances between 3-5 MOhm 
when filled with the following pipette solution (in mM): 110 NaCl, 10 Na4-EGTA, 4 MgCl2, 10 HEPES, 
and 10 Glucose (pH 7.4 and osmolarity between 285-290 mOsm). The bath solution contained (in mM): 
145 NaCl, 3 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES, and 15 Glucose (osmolarity between 310-315 mOsm and 
pH 7.35). Series resistance (always < 20 MOhm before compensation) was electronically compensated 
60 to 90 %. For recordings at physiological temperature, warm solution was perfused by gravitation in 
the recording chamber via an HPT-2 in-line heater (ALA Scientific Instruments, USA) controlled by a TC-
10 temperature controller (NPI Electronic, Germany). Temperature at the recording chamber was 
monitored via a thermistor placed in the chamber and it was maintained at 36  1 °C. Light-stimulation 
was achieved using a 480 nm diode (5 W Luxeon rebel color with Lambertian dome; Philips Lumileds) 
controlled by a custom-built controller. Stimulation protocols consisted of 1 s-long light steps at 
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different intensities (0.08, 0.14, 0.19, 0.23, 0.27 mW mm-2), with a 11 s-long dark period in between, 
or a 10 s-long light chirp linearly-increasing from 0.1 to 100 (or 500) Hz and maximum amplitude of 
0.27 mW mm-2 (following a 1 s-long pre-pulse at half maximum intensity). The LED output faithfully 
followed the voltage command up to at least 5 kH. Light-elicited currents were analyzed offline in 
Matlab 2011b/2014b (Mathworks, USA), Igor Pro 6/7 (Wavemetrics, USA) and OriginPro 7 (OriginLab, 
USA), this included the correction of baseline drifts during the 10 s-long chirp recordings. For 
recordings at 36°C occasionally spike-like artifacts occurred due to the in-line heater. Those spikes 
were removed for display purposes in Figure 1. 
2.5.5 Dissociation and culture of hippocampal neurons, AAV infection and immunocytochemistry 
E18 pregnant Wistar rats were sacrificed using CO2, embryos were removed and heads of embryos 
were placed in a 10 cm petri dish containing ice-cold dissection media (HBSS (Gibco) + 10 mM Hepes 
(Gibco)). Brains were removed and collected in fresh dissection medium. Hippocampi were separated 
from the brain and meninges were removed. Hippocampi were digested with 2 ml pre-warmed 37°C 
0.05 % trypsin-EDTA (Gibco, Germany) for 20 min at 37°C. Trypsin was removed and the tissue was 
washed three times with 4°C dissection medium. Dissection medium was replaced with 1 ml pre-
warmed NB+ (Neurobasal with 1X B-27 supplement, 1X Glutamax and Penicillin (5,000 U ml-
1)/Streptomycin (5000 µg ml-1); all from Gibco) and tissue was triturated by gentle pipetting. The tissue 
suspension was filtered through a 100 mm cell strainer (BD Biosciences). Cells were counted using the 
trypan blue exclusion method and cultured on 12 mm glass coverslips (Thermo Scientific) coated with 
poly-D-lysine (PDL, Sigma) dissolved in 0.1 M borate buffer, in 24-well plates (CytoOne) at a density of 
80,000 hippocampal neurons per cm2 in NB+ medium in a Hera Cell 240i cell culture incubator (Thermo 
Scientific) at 37°C and 5 % CO2. On DIV 10 neurons were infected with 1 µl AAV2/6 Chronos, AAV2/6 
Chronos-ES/TS or the same constructs packed in PHP.B virus capsid. 72 h after infection neurons were 
briefly washed with pre-warmed PBS and then fixed with 4 % PFA at RT for 10 min. After fixation and 
several steps of washing, neurons were subjected to immunocytochemistry (rabbit anti-Map2 primary 
antibody, 1:1000, Abcam and goat anti-rabbit Alexa 555 secondary antibody, 1:1000, Invitrogen) and 
later on to confocal microscopy (Leica SP5). 
2.5.6 Virus purification 
AAVs were generated in HEK-293T cells (ATCC) using polyethylenimine transfection (25.000 MW, 
Polysciences, USA) (Gray et al, 2011; Deverman et al, 2016). In brief, triple transfection of HEK-293T 
cells was performed using pHelper plasmid (TaKaRa/Clontech), trans-plasmid providing viral capsid 
PHP.B (generous gift from Ben Deverman and Viviana Gradinaru, Caltech, USA) and cis-plasmid 
providing Chronos or Chronos-ES/TS (Figure 1A). The cell line was regularly tested for mycoplasma. We 
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harvested viral particles 72 h after transfection from the medium and 120 h after transfection from 
cells and the medium. Viral particles from the medium were precipitated with 40 % polyethylene glycol 
8000 (Acros Organics, Germany) in 500 mM NaCl for 2 h at 4°C and then after centrifugation at 4,000 
g for 30 min combined with cell pellets for processing. The cell pellets were suspended in 500 mM 
NaCl, 40 mM Tris, 2.5 mM MgCl2, pH 8, and 100 U mL-1 of salt-activated nuclease (Arcticzymes, USA) 
at 37°C for 30 min. Afterwards, the cell lysates were clarified by centrifugation at 2,000 g for 10 min 
and then purified over iodixanol (Optiprep, Axis Shield, Norway) step gradients (15 %, 25 %, 40 % and 
60 %) (Zolotukhin et al, 1999; Grieger et al, 2006) at 58,400 rpm for 2.25 h. Viruses were concentrated 
using Amicon filters (EMD, UFC910024) and formulated in sterile phosphate-buffered saline (PBS) 
supplemented with 0.001 % Pluronic F-68 (Gibco, Germany). Virus titers were measured using AAV 
titration kit (TaKaRa/Clontech) according to manufacturer’s instructions by determining the number 
of DNase I resistant vg using qPCR (StepOne, Applied Biosystems). Purity of produced viruses was 
routinely checked by silver staining (Pierce, Germany) after gel electrophoresis (Novex™ 4-12 % Tris-
Glycine, Thermo Fisher Scientific) according to manufacturer’s instruction. The presence of viral capsid 
proteins was positively confirmed in all virus preparations. Viral stocks were kept at -80 °C until 
experimental day. 
2.5.7 Transuterine AAV injection into the cochlea 
For in vivo transduction, anesthesia was induced with a mixture of ketamine and xylazine 
(0.125/5 mg kg-1) and maintained with isoflurane (1 %–2 %). Viral inoculum (~250 nl, 4e+8 particles μl-
1) was microinjected through the uterus into the mouse otocyst from E11.5 to E12.5 as previously 
described (Brigande et al, 2009; Reisinger et al, 2011). Only the left otocyst of each embryo was 
injected. The non-injected contralateral ear served as an internal control. AAV2/6_hSyn_Chronos-GFP 
and AAV2/6_hSyn_Chronos-ES/TS were purchased from the University of North Carolina Vector Core, 
Chapel Hill, USA. 
2.5.8 Postnatal AAV injection into the cochlea  
Postnatal AAV-injection into scala tympani of the left ear via the round window was performed at p5-
p7 wild-type C57BL/6 mice essentially as described (Akil et al, 2012) using AAV-PHP.B viral capsids and 
hSyn promoter to drive transgenic expression of opsins in SGNs. In brief, under general isoflurane 
anaesthesia and local analgesia achieved by means of xylocaine, the left ear was approached via a 
dorsal incision and the round window membrane was identified and gently punctured using a 
borosilicate capillary pipette that was kept in place to inject approximately 1-1.5 µl of AAV2/6_hSyn-
Chronos (2.33E+12 GC ml-1), AAV2/6_hSyn-Chronos-ES/TS (2.2E+12 GC ml-1), PHP.B_hSyn-Chronos-
GFP (1.07E+12 GC ml-1) or PHP.B_hSyn-Chronos-ES/TS-EYFP (2.31E+12 GC ml-1). After virus application, 
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the tissue above the injection site was repositioned and the wound was sutured and buprenorphine 
(0.1 mg kg-1) was applied as pain reliever. Recovery of the animals was then daily tracked. In all 
experiments, mice were randomly selected for injection. No blinding was possible since injections have 
to be performed in the left ear leaving the right ear as an internal control. Hence, surgery prior to 
stimulation needed to be done in the injected ear. Animals were then kept in a 12 h light/dark cycle, 
with access to food and water ad libitum. All experiments were done in compliance with the national 
animal care guidelines and were approved by the board for animal welfare of the University Medical 
Center Goettingen and the animal welfare office of the state of Lower Saxony (Animal protocol no. 
17_1726). The calculation of animal number was performed prior to starting experiments. We planned 
to use the Wilcoxon Rank Sum Test and an error probability alpha smaller than 0.05, a power (1-beta) 
of 0.95 and effect size depending on the precise experimental protocol. 
2.5.9 Immunostaining and imaging of cochlear cryosections 
Cochleae were fixed with 4 % paraformaldehyde in phosphate buffered saline (1 h). Sections of the 
cochlea were cryosectioned following 0.12 M EDTA decalcification. After incubation of sections for 1 h 
in goat serum dilution buffer (16 % normal goat serum, 450 mM NaCl, 0.6 % Triton X-100, 20 mM 
phosphate buffer, pH 7.4) primary antibodies were applied over night at 4°C. The following antibodies 
were used: chicken anti-GFP (catalog n.: ab13970, Abcam, 1:500), guinea pig anti-parvalbumin (catalog 
no.: 195004, Synaptic Systems, 1:300). Secondary AlexaFluor-labeled antibodies (goat anti-chicken 488 
IgG (H+L), catalog no.: A-11039, Thermo-Fisher Scientific, 1:200; goat-anti guinea pig 568 IgG (H+L), 
catalog no. A1107, Thermo-Fisher Scientific, 1:200) were applied for 1 h at room temperature. 
Confocal images were collected using a SP5 microscope (Leica) and processed in ImageJ. Expression 
was considered positive when FP fluorescence in a given cell (marked by parvalbumin) was found to 
be higher than 3 SD above the background fluorescence of the tissue. 
For FP localization analysis line profiles (length: 7.5 µm, 7.5 µm and 1.5 µm for SGNs, HEK cells and 
hippocampal neurons, respectively, width: 3 pixels) were centered to the outer edge of the estimated 
cell membrane. The line profiles were oriented perpendicular to the cell edge. Sample size was 1, 1 
and 3 per cell for SGNs, HEK cells and hippocampal neurons, respectively. For membrane/intracellular 
expression ratio a maximum peak detection was performed for membranous area (defined as -11 µm, 
-11 µm and -0.50.3 µm for SGNs, HEK cells and hippocampal neurons, respectively) and for intracellular 
area (defined as 1.12 µm, -1.12 µm and 0.40.5 µm for SGNs, HEK cells and hippocampal neurons, 
respectively). 
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2.5.10 STED microscopy  
Images were acquired using an Abberior Instruments Expert Line STED microscope, with excitation 
lasers at 488 nm and STED lasers at 595 nm, 1 W using a 1.4 NA 100x oil immersion objective, either in 
confocal or in 2D-STED mode. 
2.5.11 Optical stimulation in vivo  
The left bulla was reached using a retroauricular approach and opened to expose the cochlea. A 
50/200 µm optical fiber coupled to a 594 nm laser (OBIS LS OPSL, 100 mW, Coherent Inc.) was inserted 
into the cochlea via the round window. Irradiance was calibrated with a laser power meter 
(LaserCheck; Coherent Inc.). 
2.5.12 Auditory brainstem responses  
For stimulus generation and presentation, data acquisition, and off-line analysis, we used a NI System 
and custom-written Matlab software (The MathWorks, Inc.). Optically-evoked ABRs (oABRs) and 
acoustically-evoked ABRs (aABRs) were recorded by needle electrodes underneath the pinna, on the 
vertex, and on the back near the legs. The difference potential between vertex and mastoid subdermal 
needles was amplified using a custom-designed amplifier, sampled at a rate of 50 kHz for 20 ms, 
filtered (300–3000 Hz) and averaged across 1000 and 500 presentations (for oABRs and aABRs, 
respectively). The first ABR wave was detected semi-automatically with a custom-written Matlab script 
in which the wave was detected for each trace in a temporal window defined by the user and for which 
the amplitude was bigger than the average + 2 standard deviations. Thresholds were determined by 
visual inspection as the minimum sound or light intensity that elicited a reproducible response 
waveform in the recorded traces. 
2.5.13 Juxtacellular recordings from single putative SGNs  
For auditory nerve recordings, glass microelectrodes (~50 MΩ) were advanced through the posterior 
end of the anteroventral cochlear nucleus using an Inchworm micro-positioner (EXFO Burleigh, NY, 
USA) and aimed towards the internal auditory canal. Action potentials were amplified using an ELC-
03XS amplifier (NPI Electronic, Tamm, Germany), filtered (300–3000 Hz), digitized (National 
Instruments card PCIe-6323), analysed and prepared for display using custom-written Matlab (The 
MathWorks, Inc.) software. When light-responsive fibers were found, 400 ms-long pulse trains at 
repetition rates 20-1000 Hz were presented, leaving 100 ms inter-train recovery over 20 iterations for 
each tested rate. Different rates were tested following no particular order, being 20 Hz the first 
repetition rate presented across all units. For repetition rates higher or equal to 200 Hz, parameters 
were computed if the spike probability was equal or superior to 5 %. If not, values were set to 0. Phase-
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locking was quantified using the vector strength (Goldberg & Brown, 1969), considering a cycle starting 
at the onset of a light pulse and ending at the onset of the subsequent pulse, and conforming to the 









, being Θ1, Θ2, …, Θn cycle phases in which spikes 
occurred. The Rayleigh test was used to evaluate the significance of vector strength: if L > 13.8, the 
null hypothesis is rejected at the 0.001 significance level (Hillery & Narins, 1987) and insignificant VS 
were set to 0. The spike probability was calculated as the ratio between the number of spikes and the 
number of light-pulses. The temporal jitter is the standard deviation of spike latency across trials. The 
hazard function (for the temporal jitter analysis) was calculated for each stimulation rate by simulating 
spiking as a Poisson process at given rates (from 10 to 1000 spikes s-1). 
2.5.14 Data analysis 
The data were analysed using Matlab (Mathworks), Excel (Microsoft), Igor Pro (Wavemetrics), FIJI 
(ImageJ2), Origin (Microcal Software), and GraphPad Prism (GraphPad Software). Averages were 
expressed as mean ± SEM or mean ± SD, as specified. References to data in the main text were 
expressed as mean ± SEM. For statistical comparison between two groups, data sets were tested for 
normal distribution (the D’Agostino & Pearson omnibus normality test or the Shapiro-Wilk test) and 
equality of variances (F-test) followed by two-tailed unpaired Student’s t-test, or the unpaired two-
tailed Mann-Whitney U test when data were not normally distributed and/or variance was unequal 
between samples.  
For evaluation of multiple groups, statistical significance was calculated by using one-way ANOVA test 
followed by Tukey’s test for normally distributed data (equality of variances tested with the Brown-
Forsythe test) or one-way Kruskal-Wallis test followed by Dunn’s test for non-normally distributed 
data. 
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3.1 Abstract 
The cochlea, harboring the hearing end organ of Corti, is an intricate structure hidden in the temporal 
bone. Compared to other sensory organs such as the eye, the cochlea has remained poorly accessible 
for investigation, for example, by imaging. This limitation also concerns the further development of 
technology for restoring hearing in case of cochlear dysfunction, which requires quantitative 
information on spatial dimensions and neural status of the cochlea. Here, we employed phase-contrast 
X-ray tomography and light sheet microscopy for multiscale imaging of cochlear morphology in species 
that serve as established animal models for auditory research. We provide a systematic reference for 
morphological parameters relevant for cochlear implant development for rodent and non-human 
primate models. Based on imaging inserted electrical and optical cochlear implants we derive a 
baseline for functional studies on hearing restoration. We simulate the spread of light from the 
emitters of the optical implants within the reconstructed cochlea, which indicates a spatially narrow 
excitation of opsin-expressing spiral ganglion neurons. Finally, we devised an automated approach for 
estimating the fraction of transduced spiral ganglion neurons based on light-sheet microscopy of the 
cleared cochlea. 
3.2 Significance Statement 
For developing the optical cochlear implant (oCI), knowledge of the cochlear morphology is crucial. 
Here, we employed multiscale X-ray and fluorescence imaging for quantitative assessment of scala 
tympani, scala vestibule et media and Rosenthal’s canal for species commonly used in auditory 
research. Further, we demonstrate feasibility of oCI implantation for rodents and the marmoset, as a 
non-human primate model. Using modeling of light propagation from the emitters of the oCI we 
estimate the frequency selectivity and range covered by optical stimulation in the cochlea. 
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3.3 Introduction 
In case of profound sensorineural hearing impairment, cochlear implants (CIs) partially restore hearing 
by providing auditory information to the brain. Electrical stimulation of the spiral ganglion neurons 
(SGNs) enables speech understanding in the majority of the approximately 500,000 users worldwide. 
However, current clinical CIs are limited from their wide current spread (Kral et al., 1998) resulting in 
a limited coding of spectral information (Kang et al., 2009). Recently, cochlear optogenetics was 
proposed to use light to drive the auditory nerve (Duarte et al., 2018; Hernandez et al., 2014; Mager 
et al., 2018; Wrobel et al., 2018). As light can be better confined in space, future optical CIs (oCIs) with 
lower spread of excitation in the cochlea promise improved speech comprehension in noisy 
background as well as greater music appreciation (Dombrowski et al., 2018; Jeschke and Moser, 2015). 
For oCIs to be developed towards a medical device, currently major efforts are undertaken to devise 
multichannel optical stimulators for the cochlea (Ayub et al., 2016; Goßler et al., 2014; Klein et al., 
2018; Schwaerzle et al., 2016). As is the case for the electrodes of current CIs, future oCIs will place 
multiple stimulation channels, here microscale emitters, along the tonotopic axis of the cochlea. 
Further development of the oCIs requires precise estimates of parameters such as scala tympani size, 
bending radius, appropriate encapsulation and probe stiffness. Moreover, cochlear optogenetics 
employs gene transfer to the SGNs for which adeno-associated viruses (AAVs) seem promising 
candidate vectors (Hernandez et al., 2014; Mager et al., 2018; Wrobel et al., 2018). AAV delivery has 
used injection of virus suspension via the round window (Mager et al., 2018) or directly into the 
Rosenthal’s canal (Wrobel et al., 2018). Estimation of the required virus load for injection into the 
cochlea relies on understanding the volumetric proportions of the inner ear. Therefore, the volumes 
of Rosenthal’s canal and the scalae tympani, vestibuli et media needed to be evaluated. Finally, the 
efficiency and safety of viral gene transfer requires the quantification of SGN density and transduction 
rate. 
Employing multiscale X-ray and fluorescence imaging, here we provide a comprehensive analysis of 
cochlear morphology for mouse, rat, gerbil, guinea pig and marmoset as animal models for auditory 
research. Each of these animal models offers unique advantages. The mouse is readily available for 
optogenetic manipulation (e.g. (Zeng and Madisen, 2012). Channelrhodopsin-expressing transgenic 
lines are available also for rats (Tomita et al., 2009; Witten et al., 2011) that offer a larger cochlea and 
can carry larger weight implants then mice (Irving et al., 2013; King et al., 2016; Lu et al., 2005). Gerbils 
and guinea pigs are established rodent models for auditory research and offer a larger cochlea. Gerbils, 
which have low frequency hearing more similar to human, have already been employed for cochlear 
optogenetics (Wrobel et al., 2018). Finally, we focus our analysis on the marmoset, as a well 
established non-human primate model for auditory research (e.g. (Johnson et al., 2012; Osmanski and 
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Wang, 2011). Marmosets possess a rich vocalization, are highly communicative and a pitch perception 
mechanism to humans is shared (Song et al., 2016). Therefore, we compare state-of-the-art eCI to 
newly designed oCIs in marmoset cochleae and estimate the optical spread of excitation using Monte-
Carlo ray tracing simulation. 
3.4 Results 
3.4.1 Multiscale, multimodal photonic imaging of cochlear morphology 
We combined X-ray tomography and lightsheet microscopy for multiscale, multimodal photonic 
imaging of cochlear morphology. Using phase contrast X-ray tomography (Figure 1A) enabled us to 
resolved cochlear soft tissue, whereby we focused on the spiral ganglion and the basilar membrane 
(Figure 1B, C). Our custom X-ray tomography setup allowed multiscale studies of the cochlear anatomy 
down to a voxel size of 2 µm. An example of a raw volume rendering of a guinea pig cochlea dataset is 
shown in Figure 1C. The hemisected cochlear reconstruction reveals the scalae tympani and media et 
vestibule, separated by the basilar membrane as well as the Rosenthal canal. The same set-up enables 
the analysis of differently sized cochleae from various species: from mouse to marmosets (Figure 1D). 
The species differ in shape, number of turns, overall size of the cochlea and position of the round and 
oval window can be appreciated in Figure 1D. Human data were reconstructed from published micro-
CT data. Quantification of the cochlear morphology as required e.g. design of appropriately shaped 
and sized o/eCIs as well as for modeling of SGN-stimulation via CI is presented below. 
Lightsheet microscopy was performed by Carlos Duque Afonso and the results are not included in this 
thesis. 
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Figure 1. 3D models of rodent and primate cochleae 
(A) Experimental setup. X-ray beam is generated by a liquid-metal jet microfocus tube and are detected 
by a high-resolution scintillator-based CCD camera. 
(B) Raw 2D projection before wave propagation and phase retrieval algorithm. 
(C) Volume rendering of reconstructed image stack. Scala tympani (blue), scala vestibuli et media 
green), Rosenthal’s canal (purple), osseous spiral lamina (orange), basilar membrane (black line) and 
modiolar axis (dashed line). 
(D) Segmented cochleae visualized with bone (gray), basilar membrane (green) scala tympani (blue), 
round window (dashed line), oval window (dotted line) and apex (arrow). Scale bar 1 mm. 
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Figure 2. Measurements of the scala tympani crucial for cochlear implantation 
(A) Segmented scala tympani with smoothed centerline beginning at the round window (red dot). 
Centerline was used as trajectory for virtual cross-sections (gray). 
(B) Smallest radius of the scala tympani from base to apex. Data were scaled along the distance 
dimension to fit the mean length of the scala tympani. The shaded region indicates the standard 
deviation of the mean, n as in (C). 
(C) Measurements of parameter crucial for cochlear implant design considerations. Diameter is derived 
the centerline calculation, height and width were determined in virtual sections, curvature represents 
the radius from the modiolar axis to the centerline of scala tympani. N indicated animal count. Please 
note that the different species are plotted in different scales. 
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3.4.2 Quantifying scala tympani for cochlear implant design and insertion 
For considerations on CI design and for modeling of SGN-stimulation via CI measurements of the scala 
tympani are most crucial, as this is where the CI electrodes are placed. Here, we quantified X-ray 
tomography data. Following 3-dimensional reconstruction (Figure 1), we calculated the centroid for 
virtual sections of scala tympani along the turns by determining the minimum radius by means of the 
closest point on the cavity’s surface for each sampling point (Figure 2A). This resulted in a centerline 
for scala tympani (Figure 2A). For all analyzed species, the minimum radius was largest at the cochlear 
base close to the round window and smallest at the apex (Figure 2B). Assuming an CI covering 60 % of 
scala tympani length (Lee et al., 2010), the front of the CI should be limited to a radius of 
0.13 mm/0.12 mm/0.12 mm/0.15 mm/0.23 mm/0.44 mm in mice, rats, gerbils, guinea pigs, 
marmosets and humans, respectively (Figure 2B, see also Table 1). The automatically determined 
diameter was identical with the height resulting from semi-automatic measurements on virtual 
sections, which indicates accuracy of the automatic analysis. 
The bending radius, here referred to as radius of curvature (short curvature), has great relevance for 
the design of waveguide-based and light-emitting diode (LED) oCIs. LEDs such as blue GaN-LEDs 
(Laubsch et al., 2010) are stiff, and hence their size and pitch within the array on a flexible substrate 
(Goßler et al., 2014) need to accommodate the curvature of the coiled scala tympani. To be able to 
cover 60 % of the cochlear length in mice a radius of curvature of 0.29 mm has to be obeyed. In 
contrast, the cochleae rats, marmosets or humans provide greater radii of curvature: 0.51 mm, 
0.80 mm and 1.64 mm. Regardless, all radii of curvature require the use of microscale LEDs (µLEDs) for 
the sake of optoelectronic (active) oCIs. Considering such µLED–based oCIs that feature a mostly two-
dimensional shape due to their circuit plane, an oval-shaped design of the oCI could make use of the 
about 1.9 times larger width compared to the height of the tympanic duct. 
3.4.3 Insertion studies for oCI and eCI in different species 
When starting the insertion studies, we first tested various combinations of carrier materials and 
encapsulations in explanted mouse cochleae. Among the first attempts of an oCI insertion we used a 
plain polyimide substrate of 15 µm thickness without encapsulation. It could be implanted into the 
mouse cochlea up to its full length of 5 mm, but in subsequent X-ray tomography was shown to cut 
through the basilar membrane (Figure 3A inset). Hence, we thereafter encapsulated the probes. We 
first turned to dipping into silicone and thereafter spinning the probes, which resulted in a cylindrical 
shape of the polyimide-based probes and mechanical properties that were very well suitable for 
implantation (Figure S2). 
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We then turned to encapsulating µLED arrays following the design published earlier (Goßler et al., 
2014). Those encapsulated µLED arrays could be inserted into scala tympani via the round window for 
approximately 4.7 mm without detectable damage to the cochlea (Figure 3A, see also Table 2). When 
approximating the frequency-place map of Greenwood (Greenwood, 1990), the insertion covered a 
frequency range from 2.572.2 kHz of a total hearing range from 0.679.3 kHz which corresponds to 4.9 
out of 7.0 octaves. The 93 µLEDs accommodated on the 4.6 mm intracochlear portion would 
correspond to a dense coverage of approximately 20 channels per octave. Further, µLED orientation 
appeared optimal: the active µLED surface was facing Rosenthal’s canal. 
 
Figure 3. Implantation trials in rodent cochleae 
(A) Mouse cochlea with an optical cochlear implant comprising 93 µLEDs covering a frequency range 
from 72.2-2.5 kHz. Insertion depth: 4.6 mm. Basilar membrane is color-coded for corresponding 
frequency, Rosenthal’s canal (purple), LED (blue), silicone (light blue) and bone (gray). View from 
lateral. Inset shows a mouse cochlea with a probe penetrating the basilar membrane (green) at 0.5 
turns. In this case the polyimide substrate (blue) was not encapsulated in silicone. View from medial. 
Scale bar: 1 mm. 
(B) Rat cochlea with an optical cochlear implant comprising 13 µLEDs covering a frequency range from 
49.4-6.7 kHz. Insertion depth: 3.6 mm. View from lateral. 
We next turned to species with larger cochleae for investigating the utility of mold encapsulation. 
Using a state-of-the art mold-injection process, a low-density µLED array (13 µLEDs, pitch of 300 µm) 
was encapsulated yielding an outer diameter of 340 µm. The probe was inserted into scala tympani of 
a rat cochlea in situ. This way we achieved an implantation depth of 3.6 mm (Figure 3B). Despite the 
round profile orientation of the probe, µLEDs were well positioned in regard to the Rosenthal’s canal. 
However, the insertion depth was much inferior to what we found above with probes coated by 
dipping and spinning in the smaller cochlea of the mouse (Figure 3A). 
Finally, we performed a comparative insertion study of eCIs and LED-based oCIs in the marmoset, a 
non-human primate model. Using cadaver skulls, we performed a posterior tympanotomy and inserted 
the CIs via the round window. The probes were specially designed to fit the marmoset cochlea: eCIs 
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had a diameter of 300 µm with 10 electrodes and an electrode spacing of 1000 µm and 1500 µm. oCIs 
were designed to closely resemble the eCIs with 10 LEDs (250 x 200 µm) and an LED spacing of 500 µm. 
They were dip-coated in silicone with a final diameter of approximately 260 µm. eCI and oCI could be 
implanted for 8.9 mm/7.6 mm (Figure 4) covering 60 %/51% of the scala tympani, respectively. In case 
of the oCI 10 LEDs were placed on 4.5 mm with a mean distance of 671±93 µm to the centerline of 
Rosenthal’s canal. For eCIs 6 and 7 electrode contacts were located in the scala tympani with a mean 
distance of 674±24 µm.  
In regard of volumetric proportions within the cochlea, we found Rosenthal’s canal’s volume to be 
0.055 µL/0.148 µL/0.095 µL/0.366 µL/0.179 µL/3.263 µL in mouse, rat, gerbil, guinea pig, marmoset 
and human, respectively, in accordance with literature for mouse and guinea pig (Table S1). 
 
Figure 4. Implantation trials in marmoset cochleae 
(A) Optical cochlear implant in marmoset scala tympani. LED bond pads (blue), spacing between LEDs 
300 µm, silicone (bright blue), basilar membrane (color coded for corresponding frequency). View from 
cochlear base to apex. Top: Best example, insertion depth: 7.6 mm. Bottom: insertion depth: 6.4 mm. 
(B) Electrical cochlear implant in marmoset scala tymplani. Top: Best example, insertion depth: 
8.9 mm, spacing 1.5 mm. Bottom: Insertion depth: 6 mm, spacing 1 mm. 
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Table 2. Comparision of cochlear implant insertion depth across species 
Species  Mouse Rat Marmoset Human 
Scala tympani length (mm)  6.3 7.1 14.8 26.0 
Scala tympani length (turns)  2.00a 2.25a 2.75a 2.60a 
oCI insertion depth (mm)  4.5 3.6 7.6 - 
oCI insertion depth (turns)  1.43 1.14 1.41 - 
eCI insertion depth (mm)  1.0-2.0b 1.5-3.2c 8.9 21.0d 
eCI insertion depth (turns)  0.32-0.63 0.48-1.01 1.65 2.10 
a (West, 1985) 
b (Irving et al., 2013; Mistry et al., 2014) 
c (Argence et al., 2008; King et al., 2016; Lu et al., 2005) 
d (Lee et al., 2010) 
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3.5 Discussion 
In this study, we quantitatively characterized commonly used temporal bones in auditory research on 
the basis of µCT-derived models to enable design of an oCI array for use in rodents and marmosets. X-
ray tomography offered the possibility to precisely determine electrode and LED position within the 
scala tympani. The distinct advantage of 3D models is the possibility to have a digitized version readily 
available to be viewed from any angle. Further, virtual cross-sectioning gives valuable insight in 
cochlear structures and measurements that can easily be taken without manipulation of the original 
sample. However, soft tissue cannot easily be resolved and demonstrates a limitation of the method, 
thus, we employed lightsheet microscopy to be able to visualize histological details in 3D space. 
Knowledge of cochlear fine structure enabled us to implant an optical probe for 4.5 mm in mice, 
doubling insertion depth previously reported (Table 2). Likewise, in rats the oCI array could be placed 
in lower frequency regions of 6.7 kHz compared to maximum values known from literature. In case of 
a redesign of rat oCI similar to the one used in mice, using a dip coating rather than mold-injection 
encapsulation (260 µm vs. 340 µm in mouse and rat oCI, respectively), insertion depth could 
potentially be further increased. 
Implantation of eCIs in marmosets exceeded previously reported insertion depth of 8 mm (Johnson et 
al., 2012) by ~1 mm achieving a frequency-place range from 2.3-29.7 kHz estimated with the 
Greenwood function according to an audible frequency range from (Osmanski and Wang, 2011). An 
improvement in upper limit coverage was possible through round window implantation, thus, making 
use of the high-frequency hook region of the cochlea. 
Further, we now accomplished to implant 3 of 4 marmosets with specially designed 10 contact 
electrodes with an insertion depth of 12 mm estimating a lower frequency level of 920 Hz. In one 
animal, we could position 7 contacts with an insertion depth of approximately 8 mm. 
Learning from scala tympani estimation, a more complex probe design could benefit the implantation 
depth further. Considering the curve progression of the height of scala tympani is mostly linear in all 
analyzed species with a negative slope of 76.5 (R²=0.78), 65.5 (R²=0.90), 57.0 (R²=0.87), 44.4 (R²=0.93), 
33.1 (R²=0.91) for mouse, rat, gerbil, guinea pig, marmoset and human respectively, a tampered probe 
design could customize the shape to the cochlear specification. This could minimize damage to the 
sensitive scala tympani (Fan-Gang Zeng et al., 2008; Rebscher et al., 2008). 
Here, we demonstrated deepest cochlear implantation depths reported for respective animal models 
(Table 2) with specially designed optical probes. Taking together ongoing development of multichannel 
oCIs harboring µLEDs (Klein et al., 2018), optogenetic stimulation of the auditory pathway (Duarte et 
al., 2018; Keppeler et al., 2018; Mager et al., 2018; Wrobel et al., 2018) and the findings of this study, 
the future for optical cochlear implants looks promising. 
  




Cochleae were obtained from sacrificed adult CD1 and C57BL/6N mice (Mus musculus), Wistar rats 
(Rattus norvegicus), gerbils (Meriones unguiculatus), Hartley guinea pigs (Cavia porcellus) and 
common marmosets (Callithrix jacchus). A human sample (doi:10.22016/smir.o.29498) was obtained 
from the SICAS Medical Image Repository (Kistler et al., 2013) under the CC BY 3.0 license. All 
experiments conformed to the local and national guidelines for the care and use of laboratory animals 
in research and were approved by the local authorities of the State of Lower Saxony (LAVES). 
3.6.2 Sample preparation 
Surgery for optical and electrical cochlear implant was performed on fresh marmoset skulls or 
sacrificed rodents. A small retro-auricular incision was made and overlaying muscles were translocated 
to expose the middle ear or in case of rodents the bulla. The probe was implanted via the round 
window and kept in place with instant adhesive. After preparation the samples were fixated in 4% 
paraformaldehyde until imaging. Known tissue shrinkage of paraformaldehyde between 2.9 % and 
4.5 % (Fox et al., 1985; Jonmarker et al., 2006; O’Malley et al., 2009) was not corrected for. 
3.6.3 Cochlear implants 
Optical cochlear implants were designed with CreeTR2227 LEDs flip-chip bonded on flexible polyimide 
and subsequently dip-coated in silicone as described in (Schwaerzle et al., 2016) for marmosets. The 
optical probes contained 10 LEDs (size 220x270 µm) spaced with 500 µm and dip-coated in silicone 
(total diameter of approximately 260 µm). For rodents, we used integrated thin-film µLEDs (size 
50 µm) as described in (Ayub et al., 2016) with 93 µLEDs, spaced at 50 µm, tapered from 194 µm to 
160 µm, encapsulated in silicone (oval profile approx. 240x130 µm) and 13 µLEDs, spaced at 300 µm, 
encapsulated in silicone (round profile 340 µm) for mouse and rat, respectively. Electrical cochlear 
implants were kindly provided by Med-El in two different designs: Electrode spacing was 1000 µm and 
1500 µm, wires wriggled or straight for probe 1 and 2, respectively. Electrode diameter was 500 µm. 
3.6.4 MicroCT 
Anatomical and morphological features in animal models were assessed with phase-contrast 
tomography at a compact laboratory X-ray source essentially as previously described (Bartels et al., 
2013). The custom-built cone-beam in-line tomography instrument equipped with a liquid-metal X-ray 
source (JXS D2, Excillum) operated at 70 kV acceleration voltage was combined with a 20 µm LuAG-
scintillator-based fiber-coupled CCD detector (6.5 μm pixel size; C12849-102U; Hamamatsu). Fast 
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Fourier-based phase reconstruction was used to calculate the image volume. Reconstruction of the 
raw data was performed using the ASTRA toolbox (van Aarle et al., 2015, 2016). Voxel dimensions were 
isotropic, ranging from 2.00-6.63 µm. 
3.6.5 Image analysis 
Segmentation, 3D visualization of the reconstructed volume, measurements and analysis were 
performed with Avizo (FEI Visualization Sciences Group, Thermo Fisher Scientific Inc.). The raw dataset 
was initially visualized as volume rendering. Each point in the data volume is represented by scalar 
data using a user-defined colormap including alpha values. For segmentation, the µCT cross-sections 
were viewed in three orthogonal planes. Automatic histogram-based segmentation was used to 
visualize bony structures. The basilar membrane, Rosenthal’s canal, osseous spiral lamina, modiolus, 
scala tympani and scala vestibuli et media were traced with semiautomatic segmentation. In most 
cases soft tissue structures like the Reissner’s membrane could not be resolved. Thereby, the scala 
media could not be separated from scala vestibule and, thus, both cavities were lumped together in 
one fluid space. The volume of surfaces was determined based on a voxel count of the reconstructed 
spaces. The centerline was calculated with Avizo tools implementing the TEASAR algorithm originally 
described in (Sato et al., 2000). Also, the Euclidean distance to the nearest boundary was determined 
for every point of the spatial graph (591-1762 sampling points depending on species) giving an 
estimation for the radius. Subsequently the centerline tree was reduced to the relevant branch and 
smoothed with a moving average filter. In case of the scala tympani the centerline was used as a 
trajectory for virtual cross-sections (20-47 sampling points depending on species) along the spiral 
cavity. The cross-sectional area, width and height of the scalae were measured using standard Avizo 
tools. The width was determined in parallel to the osseous spiral lamina at the maximum distance 
between the lateral and medial wall. The height was also measured at its maximum, perpendicular to 
the width. The length of the basilar membrane was determined with a fitted spline along the centerline 
between lateral and medial edge. The insertion depth of CIs was measured with a fitted spline curve 
to markers along the device. 
3.6.6 Data analysis 
Parameter of the scala tympani (radius, height, width, curvature) were scaled along the distance from 
base dimension to fit the mean length of the scala tympani per species, interpolated to retrieve 100 
linearly spaced query points and subsequently averaged. For the curvature, the Euclidean distance 
between centerline and modiolar axis was determined for every sample point along the spline. 
Frequency-place estimates were derived from the Greenwood function (Greenwood, 1961, 1990) and 
fitted along the basilar membrane. Estimated audible frequency ranges were taken from (West, 1985). 
Multiscale, multimodal imaging of the native and implanted cochlea 
61 
For estimation of the corresponding frequency of individual stimulation nearest neighbor search to the 
basilar membrane was used. Data were reported with standard error of the mean if not stated 
differently. 
  




Figure S1. Cross-sectional area and perimeter 
Measurements were obtained from virtual cross-sections along the cochlea. Please note the two 
different ordinates for area and perimeter. 
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Figure S2. Implantation trials of dip-coated polyimide-based probes in mouse cochleae 
Polyimide-based probes were encapsulated via dip-coating into silicone and thereafter spun in a 
custom-built centrifuge. Two ex vivo implantation examples in translucent mouse cochleae through 
prior embedding in 2,2-thiodiethanl (TDE): 
(A) Suboptimal silicone layer with droplet formation at the tip (arrow, left and right panel). Right panel 
depicts implantation of encapsulated probe with an insertion depth of 1.8 mm. The tip of the probe 
was stuck after approximately half a turn at the lateral wall of scala tympani (view from medial side). 
(B) Optimal silicone layer without droplet formation (left panel). An implantation depth of 3.8 mm was 
achieved via the round window (dashed line). The tip of the probe (arrow) reached one turn in the 
scala tympani. Oval window (dotted line). Scale bar 1 mm.  
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4.1 One Sentence Summary 
We report the design, fabrication, and technical characterization of highly flexible LED-arrays and their 
successful application for optogenetic stimulation of the auditory pathway. 
4.2 Abstract 
When hearing fails, cochlear implants (CIs) provide the brain with auditory information that enables 
speech understanding in the majority of the approximately 0.5 million users. One important bottleneck 
of CIs is the poor spectral resolution of coding that results from the wide current spread throughout 
the cochlea from each of the electrode contacts. Optical CIs (oCIs) promise to make better use of the 
tonotopic order of spiral ganglion neurons (SGNs) inside the cochlea by more focal stimulation. Here 
we established multichannel oCIs based on microfabricated light-emitting diode (LED) arrays and 
employed them for optical stimulation of channelrhodopsin-2 (ChR2)-expressing SGNs in transgenic 
rats. Power-efficient blue LED chips (220×270 µm2, 454 nm emission) were integrated at a pitch of 350 
or 500 µm onto 15-µm-thin polyimide-based carriers comprising interconnecting lines that addressed 
individual LEDs. Thin-film passivation using a fluoropolymer was followed by silicone encapsulation. 
We extensively characterized the optoelectronic, thermal and mechanical properties of the oCIs and 
demonstrated stability over weeks. Finally, we implanted oCIs into ChR2-expressing transgenic rats 
and studied optical auditory brainstem responses (oABR) stimulated by individual or multiple LEDs. 
The oCIs could be advanced into scala tympani to cover the basal cochlear turn, as demonstrated by 
X-ray tomography. In conclusion, the study demonstrates feasibility of LED-based multi-channel oCIs. 
4.3 Introduction 
Hearing impairment (HI) is the most common sensory deficit and approximately 5% of the world’s 
population suffers from disabling HI (1). Despite the dramatic clinical need and major research 
activities, a causal therapy is not yet available for the most common form: sensorineural HI (2–4). 
Hence, hearing aids and CIs, once HI has reached severe state, will remain the key means for partial 
restoration of hearing. CIs use only 12-24 electrode contacts along the tonotopic map of the human 
cochlea, which in normal hearing allows discrimination of approximately 2000 frequency steps (5), and 
cover a frequency range of approximately 100 Hz to 10 kHz (6). Moreover, the spread of current from 
each electrode contact (7) leads to channel crosstalk (8) and diminishes the number of independent 
stimulation channels (9, 10). Optogenetic stimulation of the cochlea is a promising approach to 
increase the spectral resolution of CI coding, as the cochlear spread of excitation was shown to be 
lower for light emitted from an optical fiber with a core diameter of 250 µm than with monopolar 
electrical stimulation (11). However, much remains to be done in order to develop optical stimulation 
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as an alternative operating mode in clinical CIs (12). Next to establishing virus-mediated expression of 
opsins in auditory neurons (11, 13, 14), multichannel oCIs need to be developed. Generally, active and 
passive optical probes might be implanted into the cochlea (12). While waveguide arrays would 
passively propagate light from sources outside the cochlea, e.g. from within the sealed housing of the 
CI stimulator, active optoelectronic probes would convert current to light in encapsulated microscale 
emitters inside the cochlea. Interesting candidate emitters for blue optogenetic applications at the 
systems level are gallium-nitride (GaN) based micro LEDs (µLEDs, (12, 15, 16)). These µLEDs can be 
integrated on flexible substrates using various approaches (17–19). So far, light sources used for 
optogenetic stimulation of SGNs have been GaN LEDs and optical fibers coupled to an external laser. 
Both LEDs or fibers were either placed onto a cochleostomy or into the cochlear scala tympani via the 
round window (11) and were limited to a single stimulation channel. A fiber-based single channel 
approach was also demonstrated for photoactivation of auditory brainstem and midbrain neurons 
expressing either channelrhodopsin-2 (ChR2) or Chronos (13, 14). Clearly, single-channel optical 
stimulation has been an important step towards establishing the optogenetic control of the auditory 
pathway. However, developing oCIs for auditory research and future clinical translation requires the 
generation of multichannel devices. We have recently reported the wafer-level integration of GaN-
based µLEDs into flexible high-density arrays carrying 100 µLEDs with a size of 50×50 µm2 on a 
substrate with a length of 10 mm that fits into the cochlea of mice (18). However, the custom-made 
µLEDs were not yet optimal in terms of radiant flux (sub-mW) and wavelength (405 nm) required for 
the activation of ChR2, and robust electrical connection as well as encapsulation of the probe remained 
to be established prior to their functional characterization.  
Here, we established and characterized LED-arrays as multichannel oCIs integrating larger and highly 
power-efficient commercial GaN-based LED chips integrated on a polyimide carrier. We study 
electrical, optical and thermal properties and optimized the electrical passivation and mechanical 
properties as required for an application in the cochlea. The oCI encapsulation employed thin-film 
passivation using the fluoropolymer Cytop™, which lent the oCI stability in saline solution for weeks of 
operation with negligible leakage currents between the interconnecting lines. When further 
encapsulated in silicone, these oCIs were compatible with the use in the cochlea of larger rodents such 
as the rat. Using transgenic rats expressing ChR2-Venus under the pan-neuronal promoter Thy1.2 (20), 
we performed a first characterization of insertion and functional stimulation. This work paves the way 
for acute and chronic studies of optogenetic stimulation of the cochlea but will likely also aid 
optogenetic studies in other systems. A preliminary conference report on the technical development 
of these tools has been presented recently (21). 
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4.4 Results  
4.4.1 Design of LED-based optical cochlear implants (oCIs) 
In order to design oCIs with appropriate dimensions and mechanical properties, we first performed X-
ray tomography of the rat cochlea (22) yielding estimates of the cross-section of scala tympani and its 
curvature (Fig. 1A and B). The cross-section starts out with a width of near 1000 µm at the cochlear 
base, drops to approximately 300 µm in the mid-cochlea and then levels off. Likewise, the radius of 
curvature starts out large (approximately 1.4 mm) and declines to about 400 µm in the apex. Hence, 
our target was a slim and flexible array not exceeding 300 µm in diameter after encapsulation and 
being compatible, both mechanically as well as functionally, with a bending radius of approximately 
500 µm. 
The design of the oCIs based on a polyimide (PI) substrate and commercially available LED chips 
emitting at 454 nm is illustrated in Fig. 1C. It consists of a slender implantable section (width 240 µm) 
with a linear array of LEDs at its tip wired to the interface section designed for zero insertion force (ZIF) 
connectors. The central 11 contact pads of the ZIF connector section and the respective wiring lines (a 
broader common n-contact line and ten p-contact lines, one for each LED, inset in Fig. 1C), address 
individual LEDs for their independent control. The outer three pads on each side of the ZIF interface 
were short-circuited, hence allowing a connection test of the electrical interface in the case of these 
first oCI prototypes. The linear array of ten LEDs at the oCI tip was designed with a pitch of 500 µm or 
350 µm (see Fig. 1C). In addition, an array with four LEDs containing a temperature sensor based on a 
platinum meander integrated beneath the first LED chip was established (see Fig. 1D). The four-wire 
interconnection of this meander enables a precise resistance measurement and thus probe 
temperature determination while operating the LED chips. 
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Figure 1. Design of the LED-based multichannel optical cochlear implants. 
(A) Reconstruction of the scala tympani of a rat based on X-ray tomography, with the round window 
at the bottom and cochlear apex pointing up. Green line: center of scala tympani, blue areas: the 
exemplary cross-sections, blue lines: short and long axes of the cross-sections, black line: modiolar axis 
of the cochlea subjectively derived from the X-ray data. 
(B) Radius of curvature (dotted line), short (light blue) and long (dark blue) axes of cross-sections (area 
in green, right axis) as a function of distance from the round window. 
(C) Design of the highly flexible PI-based oCI with a linear array of ten LED chips integrated at the tip 
of the slender implantable section of the optical probe. The LEDs are individually wired and connected 
via a zero insertion force (ZIF) interface at the wider connector part comprising fixation holes for 
optional device attachment to the skull. 
(D) Design of the probe tip with resistive temperature sensor integrated beneath the first of four LED 
chips that were arranged at a pitch of 750 µm. The platinum meander of the temperature sensing 
element is connected via four wires for a precise resistance measurement. 
Multichannel LED-based cochlear optogenetics 
75 
(E, F) Optical micrographs of fabricated and silicone-encapsulated oCIs with (E) ten LED chips 
assembled at an LED pitch of 350 µm and (F) with an integrated temperature sensor beneath the first 
LED with an LED pitch of 750 µm. 
(G) Functionality test of an oCI demonstrating the individual control of LEDs prior to device passivation. 
(H) Bending test of a silicone-molded oCI inserted into a 300-µm-wide channel with an outer radius of 
1 mm milled into a PMMA substrate. 
(C,D,G) Copyright© IEEE. All rights reserved. Reprinted, with permission, from [20]. 
4.4.2 Fabrication, assembly and passivation 
The fabrication of the oCIs started by generating the PI-based carrier on a silicon (Si) handle wafer. The 
microfabrication steps, as detailed in the Supplementary Material, included the subsequent spin 
coating and curing of three PI layers patterned by reactive ion etching (RIE) sequences, the sputter 
deposition and lift-off structuring as well as electroplating of metal layers used for the integrated 
temperature sensor (first metallization), as well as LED wiring (second metallization; thickness 1 µm) 
and contact pads (third metallization; thickness 5 µm), respectively.  
The sequential integration of the LED chips onto the PI substrates employed flip-chip bonding which 
enabled the accurate and reliable assembly of individual LEDs to the electroplated bond pads by 
applying force, temperature and ultrasonic agitation. The n- and p-pads of the LEDs are clearly visible 
through the transparent LED substrate, as indicated in Figs. 1E and F. Polymeric encapsulation layers 
were manually applied after the LED assembly (Supplementary Material and Fig. S2). The oCIs received 
a polymeric underfill of the LEDs (epoxy EPO-TEK® 301-2) and were encapsulated in a thin 
fluoropolymer film (Cytop™) as well as in silicone, all applied by a manual dispensing process (Figs. 1E 
and F, and Fig. S2A) or using a precision-machined mold (Fig. 1H). The thicknesses of the fluoropolymer 
layer and underfill were in the low micrometer-range and defined by the height of the electroplated 
LED pads underneath the LEDs, while the silicone layer was about 50 µm in thickness.  
Functionality tests were performed before and after device passivation by sequentially addressing all 
LEDs (LED 1 – LED 10, Fig. 1G). In addition, motivated by the snail-like structure of the cochlea we 
tested the oCI mechanical functionality by inserting the optical implant into 300-µm-wide channels 
with different outer radii realized in polymethylmethacrylat (PMMA). We determined the minimal 
outer radius which differed depending on the LED pitch and the thickness of the silicone encapsulation. 
Figure 1H demonstrates the function of all ten LEDs of an oCI bent to an outer radius of 1 mm. This oCI 
had an LED pitch of 350 µm and was mold-encapsulated to an outer diameter of 300 µm. oCIs with an 
LED pitch of 500 µm and a silicone thickness of approximately 50 µm could be bent to a radius of only 
500 µm while remaining functional.  
4.4.3 Electrical, optical and thermal characterization of the oCI 
The electrical and optical characterization of the oCIs was performed by measuring the LED voltage V 
(Fig. 2A) and radiant flux  (Fig. 2B) as a function of the LED current ILED which was varied between 0 
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to 45 mA and pulsed at a duty cycle (DC) and a frequency of 10% and 10 kHz, respectively, resulting in 
pulses of duration tp = 4 ms. The threshold voltage of the applied LEDs was extracted from the data 
shown in Fig. 2A to Vth = 2.6 V which is comparable to the value given in the LED datasheet (23). The 
slopes of the I-V-curve are determined by the LED characteristics and the line resistance of the 
respective LED wiring, which likely explains the small differences among the various LEDs. On average 
a voltage of 4.32±0.04 V was measured at ILED = 30 mA. The measurements of the optical radiant flux 
 as a function of ILED (Fig. 2B) were performed using a calibrated integrating sphere. The LEDs of this 
representative probe showed the same behavior and provided a time averaged radiant flux of 
1.405±0.054 mW at ILED = 30 mA (10% DC and 10 kHz). This corresponds to a radiant flux of 14 mW 
during the 10-µs-long light pulses. Taking the LED foot print of 220×270 µm² into account, 
236 mW/mm² were emitted during those current pulses. Time averaged radiant emittances of 10, 15, 
and 20 mW/mm² relevant for optogenetic experiments (11) were consequently emitted at ILED = 1.25, 
1.61, and 2.27 mA, respectively. Spectral measurements of assembled and passivated LEDs showed 
light emission with an averaged center wavelength of 453.8±1.1 nm.  
Since the oCIs are active devices with limited optoelectronic conversion efficiency, we set out to 
characterize heat production and dissipation using the integrated Pt meander (Fig. 1D) to determine 
the temperature increase of the probe as close as possible to an operating LED chip. Sensor calibration 
and the measurement setup are described in detail in the Supplementary Material. Based on a set of 
transient temperature measurements performed by applying different pulse durations tp and LED 
currents ILED, the thermal time constant of the system was determined to be 11.8 ms. The experiments 
were performed with the oCI sandwiched between layers of agarose gel kept at 37°C. These conditions 
aimed to mimic the thermal properties of the perilymph fluid inside scala tympani of the cochlea. The 
experiments allowed to extract thermal relaxation functions modeling the temperature response of 
the probe to LED operation and to predict the maximum temperature increases for given LED currents 
and pulse durations. As expected, the modeled temperature evolution under the operated LED in 
response to 4-ms-long current pulses increased with ILED (producing the respective radiant fluxes Φ, 
Fig. 2C). Correspondingly, for a constant ILED (38.9 mA, maximal ILED used in physiology resulting in 
Φ = 18.1 mW) the maximum temperature Tmax rose with pulse durations tp between 0 and 10 ms (Fig. 
2D). Furthermore, Fig. 2E shows Tmax as a function of Φ for 4-ms-long pulses. Clearly, to operate the 
oCI at a given stimulation rate below a certain temperature, ILED and thus radiant flux or pulse duration 
should be limited. Since the temperature is measured within the oCI as close as possible to the heat 
source, i.e. the LED, it definitely overestimates the temperature increase in the surrounding tissue. 
Moreover, we note, that the heat dissipated by an oCI will be eliminated more efficiently within the 
scala tympani than by the agar gel of the experimental setup. We expect convection by the cochlear 
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blood flow and conduction by structures neighboring scala tympani to dissipate the produced heat, to 
which the cochlear aqueduct likely also contributes.  
 
Figure 2. Electrical, optical and thermal characterization of an oCI. 
(A) I-V curves of ten LEDs of an oCI exhibiting a threshold voltage of 2.6 V. (B) Time-averaged radiant 
flux Φ of ten assembled and passivated LEDs of an oCI as a function of the LED current ILED applied at 
10 % DC and a frequency of 10 kHz. (C) Modeled time-dependent temperature T of an oCI sample with 
integrated temperature sensor in response to current pulses of amplitude ILED and duration tp = 4 ms; 
the pulses produced the indicated radiant flux values Φ; the oCI was sandwiched in-between agarose 
gel layers kept at 37°C. (D) Modeled maximum temperature Tmax vs. tp, when LED 1 was driven with 
ILED 1 = 38.9 mA to Φ = 18.1 mW. (E) Tmax vs. Φ at tp = 4 ms. (F) Spectral density distribution of LED 1 
with peak emission at 457 nm (black line) and ChR2 normalized action spectrum (blue line) (24) with a 
peak at 460 nm (25). (G) Measured leakage currents Ileak vs. time of three representative oCI samples 
for various polymeric encapsulation procedures (Ar =  argon plasma treatment for surface activation), 
as detailed in the Supplementary Material and Fig. S2-A (up to stage vi). (H) oCI longevity derived from 
Ileak measurements, as shown in (G); oCI failure is defined by Ileak > 1 µA for more ten consecutive 
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measurement points. The temporal behavior of Ileak of samples marked by an asterisk are shown in 
panel G; dashed horizontal lines indicate a long-term measurement still running; vertical lines in each 
horizontal bar indicate the failure of a specific sample. 
4.4.4 Longevity tests 
Longevity tests were performed on oCIs which had been processed with different underfill and/or 
encapsulation materials. In saline solution, the integrated LEDs were reverse biased by a non-
permissive voltage of –5 V between their n- and p-lines measuring the leakage current Ileak (for details 
see Supplementary Material). Ileak values of three representative oCI samples show a clear dependence 
of longevity on the underfill and encapsulation procedure (Fig.  2G). The oCI indicated by blue symbols 
was underfilled using the solvent-containing fluoropolymer CytopTM only and failed already after less 
than 8 hours as evident by the increasing Ileak. In contrast, the oCI underfilled by solvent-free epoxy, 
with a surface activation by an argon (Ar) plasma before and after the underfill, survived for more than 
30 days (orange). This indicates an advantage of using a solvent-free underfill, as further detailed in 
Figs. S2-C and S2-D. Finally, combining the repeated plasma treatment with epoxy underfill and 
CytopTM encapsulation (Fig. 2G, red symbols) further increased the longevity of the oCI to more than 
200 days. These longevity results are summarized in Fig. 2H for the oCI samples characterized to date. 
We suggest, that the additional silicone encapsulation as used for the in vivo experiments, will support 
mechanical stability and further increase longevity as required for future chronic studies of 
multichannel optical stimulation. 
4.4.5 Optogenetic activation of the auditory pathway by multichannel oCIs 
Next, we turned to transgenic ChR2-Venus rats (20) in order to test the feasibility of optogenetic 
activation of the auditory pathway by multichannel LED-based oCIs. The oCIs were connected via their 
ZIF connector interface (Fig. 3A) and driven in synchrony with the recordings of auditory brainstem 
responses. Prior to each experiment we measured the emitted light power per LED as a function of ILED 
with an integrating sphere and probed the electrical integrity of the oCIs in saline solution. Then, using 
a retroauricular approach, we performed a posterior tympanotomy (“bullostomy”, Fig. 3B), inserted 
the oCI probe through the round window and gently advanced it into the scala tympany. In few cases 
we inserted the oCI through an artificial small opening of the lateral wall of the middle cochlear turn 
(cochleostomy). The position of the implant was validated by X-ray phase-contrast microscopy using a 
superbright laboratory X-ray source, as described before (22). With round window insertion and 
without forcing, the oCIs usually covered the basal turn of scala tympani (Fig. 3C). We then compared 
supra-threshold auditory brainstem responses (ABR) evoked by acoustic clicks (aABR, Fig. 3D, upper 
curve), 4-ms-long laser light pulses (oABR, Fig. 3D, middle curve, 473 nm, 6.6 mW delivered via a 
200 µm optical fiber inserted into the scala tympani via the round window) and oCI stimulation with 
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the LED-based implant (oABR, front LED, 454 nm, 6.8 mW, Fig. 3D, lower curve). The LED-stimulation 
caused an electrical onset artifact that was variable in size, preceded the oABR (asterisks mark the first 
positive peak, p1) and was followed by an artifact at the end of the stimulus. Except for these ILED-
related artifacts, the oABRs elicited by laser and LED stimulation at comparable light intensities were 
similar. Both were also comparable in amplitude, but shorter in latency when compared to aABR, and 
showed less prominent later ABR peaks. The oABR strictly depended on the intrascalar position of the 
LED (Fig. 3E): when placed in the bulla (middle ear) no oABR could be elicited. Moreover, oABRs 
vanished after euthanizing the animal, despite intracochlear stimulation (Fig. 3E). We never observed 
oABRs in ChR2-negative rats (Figs. 3E and S3). Individual LEDs of the optical implant evoked slightly 
different oABR waveforms (Fig. 3F). While the oCI contained 10 LED chips, we were typically able to 
place only up to 5 of them inside the scala tympani with gentle insertion via the round window, 
resulting in stimulation of the basal turn. X-ray tomography indicated that this was likely because the 
oCI tip did not glide further due to contact with the lateral wall. 
 
Figure 3. oCI stimulation of the auditory pathway in ChR2 transgenic rats. 
(A) Silicone-encapsulated oCI connected to a PCB via a ZIF connector in comparison to a 200 µm optical 
fiber, magnified in the lower panel. (B) Retroauricular approach to the middle ear: Surgical situs shows 
a bullostomy (dashed line) revealing the cochlea with the stapedial artery and round window. The inset 
shows the oCI inserted into the round window. (C) 3D model of an implanted rat cochlea derived from 
X-ray tomography showing the position of the LED-based oCI in the scala tympani when inserted via 
the round window. The insertion depth was 5.1 mm harboring 8 LEDs inside the scala tympani in this 
case. Note that the cochlea was reflected horizontally relative to position in (B) for easier orientation. 
(D) Comparison of aABR and oABRs evoked by laser light (473 nm) and LED light (454 nm). Top: average 
of acoustic responses to 500 clicks (300 µs) at 60 dB (SPL) applied at 20 Hz. Middle: rectangular 4-ms-
long laser stimulation at 6.8 mW and 10 Hz (average of 500 trials). Bottom: rectangular 4-ms-long LED 
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stimulation at 6.6 mW and 10 Hz (average of 500 trials). First response peak (p1) is marked with an 
asterisk. (E) oABR recordings obtained from an LED stimulation (4-ms-long duration at 8.9 mW and 
10 Hz, 500 trials) with the LED placed inside the round window (dark blue), in the bulla outside the 
round window (light blue), the first LED at the tip of the array inside scala tympani after the animal was 
euthanized (red) and in a negative ChR2 rat (control, black): only onset and end artifacts are evident 
in both cases. (F) Representative oABRs obtained from five different LEDs (8-ms-long duration at 
2.15 mW and 2 Hz, 300 trials) of an implanted oCI.  
Next, we performed a first characterization of the reproducibility and reliability of the multichannel 
oCIs. First, we compared the oABRs elicited by LED 1 of five different oCIs inserted into the scala 
tympani of the same rat via cochleostomy for most cautious insertion (Fig. 4A). The p1-morphology of 
the oABRs was qualitatively conserved with some variability of amplitude and latency (Fig. 4A-B). The 
electrical artifacts varied among oCI insertions. The p1-amplitude increased more than one order of 
magnitude as a function of light power. At high radiant flux (18 mW), stimuli as short as 100 µs were 
sufficient to elicit oABRs, which grew in amplitude with duration up to 2 ms and then leveled off (Fig. 
4C). The p1-amplitude decreased with increasing stimulus rate, but remained detectable up to 200 Hz 
(Fig. 4D). 
Next, we compared oABRs evoked by laser light (optical fiber implanted via cochleostomy) to those 
driven by an oCI (implanted via cochleostomy) in 5 different animals (Figs. 4E-H). We first studied the 
response to the laser and then inserted oCI 2 (which generated small electrical artifacts). We observed 
significant variability in oABRs to LED-1-stimulation among the animals. The oABRs evoked by the oCI 
were comparable in amplitude to those elicited by laser pulses of the same radiant flux, pulse duration 
and rate (Fig. 4F). The dependence of the oCI-evoked oABRs on pulse duration was comparable to the 
result in Fig. 4C. For the laser stimuli with their higher radiant flux, we observed a tendency of the 
oABRs to decline beyond durations of 2 ms (Fig. 4G). The rate-dependent p1-amplitude decline seemed 
shallower for LED-stimulation than for laser stimulation (Fig. 4H).  
Finally, we performed first multichannel stimulation experiments aiming to study potential additive 
effects of LEDs recruited in addition to LED 1. The reasoning was that, if, indeed, each LED only 
activated a sub-population of the spiral ganglion, the oABR amplitude should grow when recruiting 
additional, more basal LEDs that would activate further SGNs. Figure S4 shows an exemplary 
experiment in which we subsequently recruited additional LEDs and studied the effects on the oABR 
amplitude for different radiant flux, pulse durations and stimulation rates. Additivity was strongest 
when activating LED 2 in addition to LED 1 and lower gain in amplitude was found when recruiting 
further LEDs. Additivity of stimulation by multiple LEDs indicates that the spread of excitation from the 
LEDs is limited at least at a low stimulus intensity such that the more basal LEDs could drive further 
SGNs. 
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Figure 4. Characterizing oCI stimulation by recordings of oABRs in rats. 
Optical CI or optical fiber were placed on the middle cochlear turn via a cochleostomy. (A) Exemplary 
oABRs driven by LED 1 of oCIs 1-5 (color code) in the transgenic ChR2 rat used in B – D with a radiant 
flux of 18.1 mW (4-ms-long stimulus at 10 Hz, 500 trials throughout the figure). Note the onset and 
end artifacts of opposite polarity that flank the stimulus. First peak of response (p1) is marked with an 
asterisk. (B - D) oABR amplitude of p1 recorded from one rat with 5 different oCIs as a function of 
radiant flux (B, duration: 4 ms, rate: 10 Hz), stimulus duration (C, radiant flux 18.1 mW, rate: 10 Hz) 
and stimulation rate (D, 18.1 mW, duration: 2 ms). Negative standard deviation (SD) shown in light 
blue. (E) Exemplary oABRs from transgenic ChR2 rats 1-5 (color code) used in (F – H) stimulated by 
LED 1 of oCI 2. (F – H) p1 amplitude of oABRs recorded from four rats, first using a 200 µm optical fiber 
(coupling in the light of a 473 nm laser; dark grey symbols), thereafter employing LED 1 of oCI 2 (blue 
symbols), presented as a function of radiant flux (F, duration: 4 ms, rate: 10 Hz), stimulus duration (G, 
radiant flux: 18.1 mW (oCI), 27.3 mW (laser), rate: 10 Hz) and stimulation rate (H, radiant flux 18.1 mW 
(oCI), 27.3 mW (laser), duration: 2 ms). The oCI SDs are shown in light blue, laser SDs (only negative 
SDs shown) in light grey. 
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4.5 Discussion 
Here we demonstrate the technological fabrication and biological application of LED-based 
multichannel optical cochlear implants. The design and fabrication of these oCIs was guided by the 
diameter of scala tympani of the rat cochlea (>300 µm), as estimated from X-ray tomography, and the 
minimal bending radius to comply with (1 mm). This obviously placed constraints on the design of oCIs 
for rodents, also restricting the number of integrated LED chips, which in our case were individually 
addressed as is the case of electrodes in current clinical CIs. As the applied LED chips require currents 
in the mA-range for light emission that activates optogenetically-modified SGNs, line width and height 
were requested to be as large as possible. The LED dimensions of 270×220×50 µm³ were small enough 
for an implantation into the rat cochlea and large enough for LED assembly using flip-chip bonding. 
The LED size and pitch turned out to limit the bending radii of the oCI. Reducing probe dimensions and 
bending radii can be achieved by the integration of thin-film µLEDs, as recently demonstrated (18). The 
optical characterization of the radiant flux indicated that a sufficient optical power can be generated 
for optogenetic activation of SGNs, which was directly revealed by biological experiments. The 
temperature modeling based on measurements with passivated oCIs in contact with agarose gel 
enabled the determination of the implant temperature in a worst-case scenario without any cooling 
by the cochlear blood flow. For radiant emittances of 15 mW/mm2 at the LED surface we extracted a 
temperature increase of the integrated temperature sensor under an operated LED of approximately 
2 K. This seems acceptable according to the ISO 14708-1 standard for implantable medical devices 
limiting the temperature increase to 2 K. Future in vivo temperature measurements using the 
integrated Pt meander will help to set the upper limits for operating oCIs in the cochlea without a risk 
of overheating the surrounding tissue.  
The novel oCIs could readily be inserted into the scala tympani of the rat via the round window or 
cochleostomy and were capable of eliciting oABRs comparable to those evoked by laser-pulses but 
flanked by electrical artifacts. Since no leakage currents were observed, we assume that the artifacts 
were of capacitive origin, which calls for a better electrical shielding of the oCI supply lines. The oCI-
elicited oABRs were highly specific as they were absent when (i) the stimulating LED chip was outside 
the scala tympani, (ii) the animal was euthanized, and (iii) wild-type rats lacking ChR2-expression in 
SGNs were stimulated. Sequential insertion of several oCIs into a given rat cochlea as well as the 
subsequent insertion of one oCI in several rats was possible and compatible with function, indicating 
general utility as well as sufficient mechanical and electrical stability of the oCI prototypes. While some 
variability of oABRs was found with both experiments, it seemed less pronounced than in our previous 
experiments where oABRs were vastly different in response to the focused light of a power-LED (11).  
Importantly, maximal oABR amplitudes, thought to relate to the number of SGNs that were 
synchronously activated by the LED, were in the low µV range, quite similar to aABR, but much smaller 
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than what we had previously reported for oABRs for mice (11). This suggests better specificity of 
activation of the auditory pathway by oCIs in the present study. The observed oABR amplitudes grew 
over more than one order of magnitude of radiant flux and did not show evidence for saturation, which 
indicates a large dynamic range of optical coding (more than 20 dB, typically less than 10 dB in 
electrical CI (6)). Unlike in our previous study, where oABRs failed even below 100 Hz (11), we could 
demonstrate oABRs elicited by oCIs in ChR2-transgenic rats for stimulus rates as high as 200 Hz. While 
we cannot fully explain this discrepancy, we speculate that it, too, might relate to more specific 
activation of the auditory pathway in the present study.  
Much remains to be done in order to develop multichannel oCIs as tools for research and for future 
translation into the clinic. As an example, long-term in vitro testing of mechanical and optoelectronic 
integrity as well as chronic implantation studies of reliability and safety will be required. Moreover, 
while our study provides a basic proof of functionality for a few LEDs, future studies will aim at 
establishing and characterizing arrays with a higher emitter density. Thin-film GaN µLEDs are well 
established and can reach power efficiencies of up to 50% (25). Hence, they are good candidates as 
emitters for ‘active’ blue oCIs (12). However, as Lambertian emitters they are not ideal for providing 
highly focused optical stimulation. Focusing by micro-lenses (27) and/or ‘modiolus-hugging’ (28) in 
order to bring the oCI as close as possible to the medial wall of the cochlea and to let the LEDs directly 
face the SGN somas in Rosenthal’s canal can be expected to reduce the spread of light. However, even 
without optimization LED-stimulation might realize some spatial selectivity. In our study, a first test of 
simultaneous multichannel optical stimulation using LED-based oCIs showed an increase of oABR 
amplitude at least upon the recruitment of one additional LED. We suggest that this reflects 
independence of both LEDs regarding SGN activation to some extent, as it likely happened at different 
tonotopic positions. Future characterization of the spread of optogenetic excitation by multichannel 
µLED oCIs will require recordings from the auditory midbrain, where the central nucleus of the inferior 
colliculus provides convenient access to the tonotopic map (10, 26–28). 
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4.6 Materials and methods 
See supplemental information. 
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4.9 Supplementary information  
Supplementary materials and methods 
Supplementary Fig. S1. Fabrication of the highly flexible oCI substrates. 
Supplementary Fig. S2. Assembly and passivation of oCIs. 
Supplementary Fig. S3. oCIs do not evoke potentials in littermate control rats lacking ChR2 or in dead 
ChR2-positive rats. 
Supplementary Fig. S4. Additivity of LEDs in eliciting oABRs. 
 
Supplementary Movie S1. Visualization of implanted cochlea by high resolution X-ray tomography.  
3D-visualization of an explanted rat cochlea obtained by X-ray phase contrast tomography first 
displayed as raw X-ray sections and volume rendering representing pixel values in grey scale. 
Segmented model reveals LEDs (blue), basilar membrane (green) scala tympani (turquois) and 
Rosenthal’s canal (purple). Towards the end the camera follows the path of the oCI into the scala 
tympani via the round window. 
 
Supplementary Movie S2. Visualization of oCI stimulation in the explanted rat cochlea.  
Explanted rat cochlea submerged in thiodiethanol (to render the bone translucent) with fully 
implanted 10 LED oCI in the basal turn via the round window. LEDs were activated via fast Fourier 
transformed audio track signal.  
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4.10 Supplementary materials and methods 
4.10.1 Microfabrication of the optical cochlear implant substrates 
Figure S1 summarizes the microfabrication of the highly flexible triple layer polyimide (PI) substrates. 
Their total thickness of 15 µm results from three layers of PI and three metal layers. A first 5-µm-thick 
PI (UPIA-ST, UBE Europe GmbH, Duesseldorf, Germany) layer was spin-coated onto a silicon (Si) handle 
wafer and cured at 450°C for 3 h (Fig. S1-A). This was followed by the first metallization (platinum (Pt), 
250 nm) which was sputter-deposited after applying an oxygen plasma activation of the PI surface at 
80 W for 1 min (Fig. S1-A). This first metal layer was lift-off patterned using an image reversal 
photoresist (AZ5214E, Merck KGaA, Darmstadt, Germany). The second PI layer was spin-coated to a 
thickness of 2.5 µm and patterned using a photoresist mask (AZ9260, Merck KGaA) and reactive ion 
etching (RIE), as shown in Fig. S1-B. To improve the adhesion of this second PI layer to the PI substrate 
an oxygen plasma (80 W, 1 min) was again applied. The second metallization comprising the LED supply 
lines made use of a sputter-deposited seed layer (Pt/gold (Au)/titanium (Ti), 30/200/30 nm). The seed 
layer adhesion was improved by an argon (Ar) plasma treatment directly prior to the metal deposition. 
This was followed by deposition and patterning of a second photoresist mask, the removal of the upper 
30-nm-thick Ti adhesion layer using 1% hydrofluoric acid (HF), and electroplating of Au to a thickness 
of 1 µm for the LED wiring (Fig. S1-C). After removal of the electroplating mask, the remaining Ti and 
Au seed layers around the electroplated structures were wet etched using 1% HF and potassium 
iodide/iodine (KI/I2) solution, respectively, while the Pt layer was dry etched using an Ar plasma 
(Fig. S1-D). For the third PI layer with a thickness of 1 µm and the third metallization of the LED bond 
pads with a thickness of 5 µm we applied the same procedure as for the second layer level (Fig. S1-E-
G). The PI and thus probe patterning employed RIE using a 30-µm-thick AZ9260 photoresist as the 
masking layer (see Fig. S1-H). Finally, the oCI substrates could be peeled off the wafer using tweezers 
(Fig. S1-I). 
4.10.2 Assembly and packaging 
oCI substrates (see Fig. S2-A(i)) peeled off the handle wafer were individually turned into functional 
oCIs starting with the LED chip assembly (see Fig. S-2A(ii)). Ten LED chips (Cree® C460TR2227-S2100, 
Three Five (III-V) Materials, Inc., NY, USA) were sequentially flip-chip bonded with their n- and p-
contacts on the corresponding pads on the PI substrate. The flip-chip bonder (Fineplacer 96λ, Finetech 
GmbH, Berlin, Germany) offers an accuracy of ±5 µm; we applied a bonding force of 1.5 N at a 
temperature of 120°C and an ultrasonic energy of 300 mW. These process parameters ensure the 
mechanical and electrical interconnection of the LED bond pads to the 5-µm-high substrate pads. After 
LED assembly, we rinsed the oCIs with DI water before an Ar plasma (50 W, 1 min) cleaned and 
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activated the PI surface (Fig. S2-A(iii)). Immediately thereafter, the LEDs were underfilled with a solvent 
free epoxy (EPO-TEK® 301-2, John P. Kummer GmbH) (Fig. S2-A(iv)). The underfill was cured for 
12 hours in an oven at 120°C. A first polymeric encapsulation using Cytop™ 809 M (Asahi Glass Co. Ltd., 
Tokyo, Japan) was applied immediately after a further plasma treatment (Ar, 50 W, 1 min), as shown 
in Figs. S2-A(v) and A(vi). A soft bake of this passivation was performed in an oven at 50°C for 30 min 
and 80°C for 1 h. This stage of fabrication including an additional hard bake step at 180°C for 1 h was 
used for the longevity testing (Fig. 2G, H). For the oCI samples used in vivo, an oxygen plasma (50 W, 
1 min) was then applied (Fig. S2-A(vii)) to improve the layer adhesion of the final silicone (ELASTOSIL® 
RT 604, Wacker Chemie AG, Muenchen, Germany) passivation layer (see Fig. S2-A(iii)). The final 
annealing process was performed in two steps at 80 and 180°C, both applied for 1 h each.  
The top view and cross-sectional schematics in Fig. S2-B illustrate the layered structure of the oCI and 
the used materials in the LED area. Figures S2-C and D demonstrate the benefit of using a solvent-free 
underfill: when CytopTM was used as underfill gas bubbles were observed underneath the LEDs (Fig. S2-
D), while the use of the solvent-free EPO-TEK® 301-2 avoided bubble formation (Fig. S2-D). 
4.10.3 Experimental characterization 
The optoelectronic characterization of the oCIs was performed with a custom-made setup consisting 
mainly of a current source and an optical measurement system (OMS). The current source was built 
using a diode driver (iC-HKB, iC-Haus GmbH, Bodenheim, Germany) combined with an evaluation 
board from iC-Haus GmbH. The DAQ PCIe-6259 board (National Instruments, Austin, USA) was 
controlled by a LabView program. The LED current supplied by the driver and the voltage-drop over 
the oCI were measured and stored via the LabView program. In parallel, the program controls the OMS 
consisting of an integrating sphere (ISP-50-I-USB, Ocean Optics, Ostfildern, Germany) combined with 
a spectrometer (USB4000, Ocean Optics). It enables the radiant flux  as well as the spectral 
distribution of the emitted light to be determined. For this purpose, the LED-carrying tip of the oCI was 
inserted into the 8-mm-wide aperture of the integrating sphere while varying the LED current ILED from 
0 to 45 mA at a DC of 10% and a frequency of 10 kHz for the time-averaged radiant flux measurements. 
The thermal characterization was performed using the integrated Pt meander as a temperature 
sensing element. In a first calibration measurement, we extracted the resistance change of the Pt 
meander as a function of temperature between 22.5°C and 58.5°C. The resistance change was 
measured using a four-wire setup by applying a constant Pt meander current of 100 µA and measuring 
the voltage-drop along the Pt meander. The extracted temperature coefficient of resistance was 
2.71×10–3 K–1 at 37°C. In order to determine the temperature increase of an LED in operation, the oCI 
was sandwiched between two agarose gel slides kept at 37°C and simulating the thermal coupling of 
the probe to tissue. Measurements of the meander resistance and thus temperature as a function of 
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time were performed while applying LED current pulses of various magnitudes ILED and durations tp. 
For each combination of ILED and tp, 16 measurements were averaged. By fitting exponential relaxation 
functions to the data, a thermal time constant of 11.8 ms was extracted. As a second relevant 
parameter, the asymptotic temperature increase of the Pt meander under the LED was determined as 
well. The thermal model of the oCI allows predicting the maximal temperature increase for a given LED 
current, pulse duration and stimulation frequency. 
4.10.4 Passivation validation 
The characterization of the oCI encapsulation was performed with an automated leakage current test 
setup. Here, the oCI was connected via a ZIF connector to a printed circuit board (PCB) integrated into 
a tailored silicone plug of a test tube. The oCI was inserted into the test tube containing Ringer’s 
solution simulating the environment of the probe in the cochlea. The leakage test was performed by 
applying the maximum recommended LED reverse bias voltage of -5 V while measuring the leakage 
current Ileak between the n- and p-lines of the LED using a source meter (Model 2602A, Keithley 
Instruments, USA). The source meter was controlled via a GPIB interface using a LabView program 
storing the current value at predefined time intervals. The measurement was terminated once Ileak 
exceeded the set limit of 1.0 μA for 10 consecutive measurement points of Ileak. 
4.10.5 Animals 
Experiments were performed on adult wild-type and transgenic channelrhodopsin-2 rats of either sex 
(Thy1-ChR2-Venus, (20)). All experiments conformed to the local and national guidelines for the care 
and use of laboratory animals in research and were approved by the local authorities of the State of 
Lower Saxony (LAVES). 
4.10.6 Surgery 
For in vivo experiments transgenic rats were anesthetized with isoflurane (4 % at 1 l/min for induction, 
1-2 % at 0.4 l/min for maintenance) and appropriate analgesia was obtained with subdermal injection 
of buprenorphine. The animals were then placed onto a custom-designed heating blanket (37°C) on a 
vibration isolation table in a sound-proof chamber. Access to the left cochlea for stimulation was 
achieved by a retroauricular approach. Optical stimulation was performed through the round window 
or cochleostomy. For morphological studies we euthanized the animals with isoflurane and then 
explanted and fixed the cochlea. 
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4.10.7 ABR recordings 
oCIs or a 200-μm optical fiber coupled to a blue laser (473 nm, MLL-FN-473-100, 100 mW DPSS; 
Changchun New Industry Optoelectronics) were inserted into the cochlea via the round window (or 
via a cochleostomy, where indicated). The radiant flux of laser and oCIs were calibrated with a laser 
power meter (Gentec-EO Solo 2, München, Germany) and a custom built integrating sphere, 
respectively. The LED-based optical probes were controlled via digital-to-analog (DA) outputs achieving 
pulse sequences with a resolution of 2 µs driven with an operational amplifier. The light output was 
defined by the voltage output of the the DA. ABRs were recorded by needle electrodes underneath 
the pinna, on the vertex, and a reference electrode on the neck. The differential potential between 
vertex and mastoid subdermal needles was amplified using a custom-designed amplifier (gain 10,000), 
sampled at a rate of 50 kHz (NI PCI-6229, National Instruments), and filtered off-line (0.3 kHz to 3 kHz 
Butterworth filter) for acoustically and optically evoked ABRs. 
Stimulus generation and presentation (acoustic and optic), and data acquisition were realized by a 
customized software in MATLAB (The MathWorks, Inc.) employing National Instruments cards in 
combination with custom-built hardware to amplify and attenuate audio signals. In case of acoustically 
evoked ABRs, clicks of 0.3 ms length were presented in an open near field via a single loudspeaker 
(Vifa, Avisoft Bioacoustics) placed on average 30 cm in front of the animal at the level of the animal’s 
head. Sound pressure levels were calibrated with a 0.25-inch microphone (D 4039, Brüel & Kjaer 
GmbH) and measurement amplifier combination (2610; Brüel & Kjaer GmbH). 
4.10.8 X-ray tomography 
Positioning of the oCI was confirmed with phase-contrast tomography at a compact laboratory X-ray 
source essentially as previously described (22). The custom-built cone-beam in-line tomography 
instrument equipped with a liquid-metal X-ray source (JXS D2, Excillum, Sweden) operated at 70 kV 
acceleration voltage was combined with a 20 µm LuAG-scintillator-based fiber-coupled CCD detector 
(6.5 μm pixel size; C12849-102U; Hamamatsu). Fast Fourier-based phase reconstruction was used to 
calculate the image volume. Reconstruction was performed using the ASTRA toolbox (29, 30). 
Segmentation and 3D visualization of the reconstructed volume was performed with Avizo 3D 9 
(Visualization Sciences Group, FEI Company). Automatic histogram-based segmentation was used to 
visualize bony structures. The basilar membrane, Rosenthal’s canal, scala tympani were traced with 
semiautomatic segmentation. Insertion depth was measured with a fitted spline curve to markers 
along the oCI.  
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Figure S1. Fabrication of the highly flexible oCI substrates. 
(A) Spin coating of first PI layer on Si handle wafer and lift-off patterning of Pt metal lines forming the 
temperature-sensing element in the first metallization layer. (B) Spin coating of second PI layer, RIE 
patterning to open vias using photoresist mask. (C) Deposition of metal seed layer and patterned Au 
electroplating of the second metallization using a second photoresist mask. (D) Resist strip and seed 
layer etch. (E) Spin coating of the third PI layer and via opening using a third photoresist mask and RIE. 
(F) Metal seed layer deposition and patterned Au electroplating of the third metallization. (G) Resist 
strip and seed layer etch. (H) oCI probe patterning using a fourth photoresist mask and RIE. (I) 
Photoresist strip and peeling the patterned optical probes off the handle wafer. 
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Figure S2. Assembly and passivation of oCIs. 
(A) Individual LED assembly on the (i) flexible PI substrate using (ii) flip-chip bonding and (iii) surface 
cleaning and adhesion promotion using argon plasma treatment. (iv) LED underfill with EPO-TEK® 301-
2. (v) Argon plasma treatment for adhesion promotion and surface cleaning. (vi) Inner CytopTM 
encapsulation. (vii)  Oxygen plasma treatment for adhesion promotion and surface cleaning. (viii) 
Outer silicone encapsulation. (B) Schematic of an LED on a PI substrate illustrating the underfill and 
exposed materials. (C) Perfectly underfilled LED by using solvent-free EPO-TEK® before applying the 
CytopTM- and silicone encapsulation layers. (D) Underfill grade of 77 % by applying CytopTM showing 
gas bubbles. 
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Figure S3. oCIs do not evoke potentials in littermate control rats lacking ChR2 or in dead ChR2-
positive rats. 
Upper two traces show stimulus-locked average response to intracochlear LED-based oCI stimulation 
in a ChR2-positive rat before (blue: clear oABR, p1 labeled by an asterisk, 18.1 mW, 10 Hz stimulus 
rate, 4 ms stimulus duration) and after euthanizing (red, no oABR, only artifacts) for reference. Lower 
three traces were obtained from a ChR2-negative littermate rat at different light intensities (9.0 to 
18.1 mW, 10 Hz stimulation rate, 4 ms stimulation duration). The oCI was placed in the middle cochlear 
turn via a cochleostomy in all cases. Stimulus is displayed as blue bar. 
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Figure S4. Additivity of LEDs in eliciting oABRs. 
The oCI was placed on the middle cochlear turn via cochleostomy. oABR amplitude of p1 recorded 
from one rat with subsequent addition of up to four LEDs (light to dark blue) as a function of radiant 
flux (A), stimulus duration (B) and stimulation rate (C). LED 1 was inserted for about 3 mm, LED 4 was 




5.1 Temporal fidelity 
First demonstration of optogenetic stimulation of the auditory nerve in rodents was demonstrated by 
(Hernandez et al., 2014) in ChR2-transgenic mice under the broad neural promoter Thy1.2. Using 
transgenic animals was sufficient for first basic questions. Hernandez et al. could show activation of 
the auditory pathway with blue light. Further, use of a viral vector injected in mouse embryos on day 
11.5 with AAV2/6-hSyn carrying the ChR2 mutant CatCh was reported successfully. However, activity 
broke down at simulation rates higher than 70 Hz, well below the temporal fidelity needed for hearing 
restoration (Hernandez et al., 2014). The auditory nerve employs spontaneous firing rates of up to 
120 Hz (Liberman, 1978; Schmiedt, 1989) and sustained firing rates of several hundreds of Hz in 
mammals (Taberner and Liberman, 2005). For assumptions in humans computational models might 
close the gap from animal models to humans as physiological studies of the auditory nerve are only 
available for animals due to the invasive nature of those experiments (Verhulst et al., 2018). Recently, 
Wrobel et al. 2018 used a direct modiolar AAV-CatCh injection in adult gerbils achieving population 
responses up to 200 Hz of stimulation. The difference with the previous study likely indicates more 
specific activation of the auditory pathway, as indeed, the amplitudes of the optical evoked population 
responses were comparable to acoustic auditory brainstem responses (Wrobel et al., 2018) while they 
were 1-3 orders greater in the previous study (Hernandez et al., 2014). Juxtacellular recordings from 
individual auditory nerve fibers showed well-synchronized responses to light pulses up to 
approximately 125 Hz with some fibers following up to 500 Hz with decreased vector strength. While 
these results indicate that CatCh-mediated optogenetic activation of SGNs might enable near 
physiological firing rates, improving temporal fidelity remained an important objective. 
Therefore, in chapter 2 we biophysically characterized one of the most promising candidates for 
translation to humans: Chronos is among the fastest ChRs described to date (Klapoetke et al., 2014). 
Chronos has been used successfully in the cochlear nucleus (Hight et al., 2015), inferior colliculus (Guo 
et al., 2015) and the cochlea (Duarte et al., 2018). In our study (Keppeler et al., 2018) we found 
deactivation time constant of 3 ms (chapter 2) compared to ChR2 (deact = 9.4 ms) and CatCh 
(deact ∼ 16 ms) at room temperature. At body temperature, the deactivation time constant for 
Chronos even drops below one millisecond. The ultrafast ion-channel showed sizable oABRs on 
population level of up to 1000 Hz of stimulation and firing of single SGNs in response to trains of light 
pulses at hundreds of Hz with sub-millisecond temporal precision. These findings promise the 
possibility of physiological spiking of the optogenetically-driven auditory nerve. 
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5.2 Optogenetic manipulation of spiral ganglion neurons 
ChRs enabling neurons to spike upon light are key to enable optical cochlear stimulation. High 
transduction efficiency of SGNs within the Rosenthal’s canal and efficient trafficking of ChRs in the cell 
membrane for high light sensitivity and low proteostatic stress are important factors to consider for 
functional optogenetic hearing restoration. First, the neuronal cells in the cochlea need to be targeted. 
Most commonly, delivery of genes is achieved via virus-mediated gene transfer. This method harbors 
the benefit of high flexibility with the use and characterization of new ChR variants (Klapoetke et al., 
2014; Mager et al., 2018; Mardinly et al., 2018). Various viruses have been tested for suitability as viral 
vectors, however, only few are considered safe for application in humans (Kantor et al., 2014). 
Usage of viral vectors has the theoretical risks of cell toxicity, their malignant transformation and 
immune responses. Non-viral vectors have been used to transduce the cochleae with plasmids through 
electroporation (Pinyon et al., 2014) or attached to nanoparticles (Praetorius et al., 2007) though cell 
targeting can be limited to directly neighboring cells (Pinyon et al., 2014) and poor transduction 
efficiency has been reported (Staecker et al., 2001). 
Here, we focused on AAV-mediated gene transfer which has been most commonly used and AAV has 
emerged as one of the safest vectors to date (Lentz et al., 2012). Most critical for AAV-mediated gene 
transfer is the selection of the appropriate serotype and viral titer while age at injection appears to 
have less influence on expression levels (Yoshimura et al., 2018). Further, the viral titer correlates 
directly with general safety (Ramachandran et al., 2017). 
While cochlear optogenetics previously embarked on AAV2/6 (Hernandez et al., 2014; Mager et al., 
2018) our recent study presented in chapter 2 of this thesis used a novel AAV serotype (Deverman et 
al., 2016) with improved efficiency of neural transduction. Moreover, after initially employing 
transuterine AAV-injections we finally focused on postnatal injections that proved efficient and present 
less harm to the animals. We kept the human synapsin promoter, successfully used before for SGN-
specific transduction in the cochlea (Hernandez et al., 2014; Mager et al., 2018). Using postnatal 
injections of AAV-PHP.B substantial SGN transduction across all cochlear turns was revealed by 
immunohistochemistry, which is an important advance over the primarily basocochlear expression 
found with transuterine AAV2/6-injection. While high transduction rates were also found with AAV-
PHP.B carrying the original Chronos construct, optogenetic stimulation was not efficient owing to the 
poor membranous expression of Chronos. Only 47% of Chronos animals showed auditory population 
responses, while 95% of injected animals showed reliable peaks for Chronos-ES/TS also using the AAV-
PHP.B vehicle. Cell membrane targeting is essential for functional expression of Chronos which was 
achieved appending sequences for improved exit from the endoplasmic reticulum (ES) (Ma et al., 2001; 
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Stockklausner et al., 2001) and trafficking to the plasma membrane (TS) (Hofherr, 2005). Improved 
targeting also comes with the advantage of less proteostasis. 
In research, ChRs are fused to a florescent reporter to visualize expression effectively. For translation 
to humans it might be necessary to remove the reporter due to immune responses caused by the 
fluorescent protein (Stripecke et al., 1999) which, however, so far has not been reported for 
immunologically privileged organs like the eye (Dalkara et al., 2013). 
5.3 Light-tissue interaction 
When light is applied to tissue, photons interact with organic material in diverse manners, which can 
be mainly reduced to scattering and absorption. While scattering mostly alters the propagation path 
spreading the photons over a large area, absorption leads to energy conversion from light to 
vibrational energy within the absorbing molecules. To reduce scattering in tissue in the most effective 
way one could match the refractive index as proposed for in vivo imaging (Boothe et al., 2017), 
however, this technique would be limited to acute, laboratory experiments and not be feasible for 
translation. More realistically one could make use of red-shifted ChRs. Naturally, longer wavelengths 
harbor the benefit of increased penetration depth and more localized targeting of SGNs due to reduced 
scattering (Jacques, 2013). Narrower spread of excitation would ultimately allow a higher number of 
stimulation channels. Further, blue-light stimulation harbors a higher risk of photo-toxic damage to 
cells and tissue (Stockley et al., 2017). In principle, all wavelength of light can be harmful to cells in 
vitro depending on the dose (Frigault et al., 2009). However, the shorter more energetic wavelengths 
below 500 nm are particularly damaging (Wäldchen et al., 2015), thus, stimulation with red-shifted 
wavelength can reduce potential cellular harm (Mager et al., 2018; Magidson and Khodjakov, 2013). 
For the commonly used 470 nm blue light stimulation, a temperature increase of up to 1 K was 
reported depending on stimulation protocol (Gysbrechts et al., 2016), not considering additional heat 
evolving with active stimulators (e.g. 2 K directly at LED) as described in chapter 4. Temperature shifts 
not reaching the threshold for tissue damage might still influence cellular physiology (Moser et al., 
1993) and animal behavior (Long and Fee, 2008). Thermal effects towards the SGNs will likely be 
attenuated due to the circulating perilymph within the scala tympani along with the decay in distance, 
which is in the range of a few hundred micrometers in mice to several hundred in non-human primates. 
5.4 Advances in oCI development 
Development of optical cochlear implants heavily depends on technical advances to overcome size 
limitations within the bony boundary of the cochlea. Therefore, we employed phase-contrast X-ray 
tomography to reveal requirements given by cochlear morphology of commonly used animal models. 
This detailed study was necessary as a systematic reference was missing. The few studies available 
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used various methods from micro-dissection, microscopic analysis to phase-contrast X-ray 
tomography, which makes direct comparison difficult. Further, the majority of publications focus on 
cochlear mechanics or eCIs and lack volumetric descriptions of the Rosenthal’s canal or SGN count 
which is particularly interesting for optogenetics as the auditory nerve needs to be genetically 
manipulated, thus requiring injection of a viral vector. 
For a light emitting device, an active and a passive design are discussed (Moser, 2015). Active optical 
stimulators make use of LEDs (Schwaerzle et al., 2016b), LEDs (Goßler et al., 2014; Klein et al., 2018) 
or OLEDs (Steude et al., 2016). Fitting the micro-scaled scala tympani with its several turns presents a 
major technological challenge as it requires a highly flexible oCI design and miniaturized light emitters. 
Further, placing the optoelectronics of active oCIs within the cochlea necessitates robust passivation 
of the probe so that the circuit paths are well isolated from the highly conductive perilymph without 
the encapsulation absorbing or scattering the emitted light. Passive optical emitters consist of an 
waveguide array (Schwaerzle et al., 2016a) directing light from remote light sources. Typically vertical-
cavity surface-emitting lasers (VCSELs) (Tien-Chang Lu et al., 2009) or laser diodes could be used as a 
light sources. The biggest advantage of a waveguide based oCI would be that all active electronic parts 
would stay outside the spatially constrained cochlea, thus enabling robust sealed housing e.g. in a 
titanium case. Further, the intracochlear temperature increase discussed in chapter 4.3 can be largely 
neglected. A drawback for passive designs is the loss of light occurring during coupling and outcoupling 
into/from the waveguide. Optical beam-steering could improve the spread of light at the outcoupling 
spot regardless of the two design modalities: Microlenses (Huang et al., 2017) or microprisms (Reardon 
et al., 2009). However, the rigid lenses or prisms can negatively impact flexibility of the probe thus 
impeding smooth implantation into the scala tympani. 
Design of LED implant prototypes based on morphological parameters enabled insertion in mouse 
cochleae for first proof-of-principle experiments. The probe was oriented optimal, with the emitters 
facing the Rosenthal’s canal and an insertion depth of 4.6 mm corresponding to 71% of scala tympani. 
These findings exceed all previously reported implantation depth for mice (Irving et al., 2013; Mistry 
et al., 2014). 
For functional studies we moved on to the larger rat cochlea with oCIs carrying larger and power-
efficient LEDs for higher light output (chapter 4). The LED arrays could be implanted into the scala 
tympani, with then usually five intracochlear LEDs, each of which was capable of eliciting oABRs in ann 
additive manner. Subsequent re-insertion of the optical probe into cochlea demonstrated sufficient 
mechanical stability. However, artifacts occurred at stimulation onset and offset and flanked or even 
occluded the optical ABR. Hence, encapsulation and passivation need to be improved to exclude 
current leakage and interference with electrophysiological recordings. 
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Measurements of cochlear morphology helped to develop first chronic oCI experiments and evluate 
cochlear light spread by computer simulations (Wrobel et al., 2018). Fiber-based single channel 
implants could be established in a deafened gerbil model. As the light spread of the optical fiber within 
the cochlea could not be determined, a 3D model was used for Monte Carlo ray tracing to simulate the 
irradiance at stimulation site. Based on the maximum light intensity used in experiments (30 mW), the 
estimated maximal irradiance at the SGN somata was well within the safe range of optogenetic in vivo 
applications (Cardin et al., 2010; Han, 2012). 
For the first time, we demonstrated an acoustic perception in behavioral experiments upon optical 
stimulation in the cochlea: In avoidance behavior experiments gerbils responded to sound and light 
alike indicating an acoustic percept in both cases. 
In parallel to improvements specific for optical stimulators, oCIs might also profit from ongoing 
attempts to further advance conventional eCIs: One approach focuses on decreasing the distance from 
stimulator to spiral ganglion within the volume of the scala tympani: a modiolus-hugging probe made 
of a shape memory polymer could be pre-shaped prior to implantation with a given curvature (Ajieren 
et al., 2016). The array is straight and relatively stiff prior to insertion which enables directing it towards 
implantation site. Upon insertion the probe warms up to body temperature and reconstitutes to its 
coiled shape. Thereby, the memory-shape polymers promise a straightforward insertion and 
atraumatic modiolus-hugging in oCI decreasing the distance of Rosenthal’s canal. 
Also, application of hydrogel particles to the rear side of the CI was proposed: Located in the tympanic 
space of the cochlea, polymer components enlarge by absorbing liquid of the perilymph, thus, 
passively directing the probe further proximal (Stieghorst et al., 2016). 
5.5 Current and future work 
The key question remains: Is optical stimulation of the cochlea superior to electrical stimulation? How 
spatially confined is optical stimulation and how much better is the frequency resolution that can be 
achieved compared to that of eCI? This question cannot be addressed on ABR level, but requires 
analysis of higher stages along the auditory pathway. Commonly multichannel electrode recordings in 
the inferior colliculus (IC) or in the auditory cortex are used to indirectly investigate spatial spread of 
excitation within the cochlea. A preliminary assessment about optical spatial spread of stimulation was 
provided by (Hernandez et al., 2014) in mice: An optical fiber was placed in the basal turn of the cochlea 
while recording local field potentials with a multichannel tungsten electrode located in the IC. The 
largest response was detected in the most ventral region of the IC coding for high frequencies as 
expected from fiber stimulation close to the round window. Spread of excitation for optogenetic 





Figure 7. X-ray volume rendering of a chronically implanted gerbil. 
Volume rendering of a gerbil chronically implanted with an intracochlear LED probe (blue) and a 
flexible subcutaneous polyimide cable (orange) reaching the vertex of the gerbil head. The inset shows 
the well-placed LED array (blue) in the scala tympani facing the Rosenthal’s canal (purple). The 
implantation was atraumatic and did not show damage to the basilar membrane. Scale bar: 0.5 mm. 
For future experiments, a mobile processor (right top) could be used to enable wireless stimulation. 
The 3D model of the mobile processor was derived from 2D drawings of Daniel Weihmüller. Scale bar: 
3 mm. 
However, all current studies so far used single channel optical stimulation. Therefore, chronic 
implantation with multichannel oCIs will be essential to further address remaining questions. 
Behavioral experiments need to demonstrate the quality of the perceived input. Ongoing efforts focus 
on improvement of passivation and encapsulation of active oCIs to be used for chronic behavioral 
experiments. In a first proof-of-principle experiment chronic implantation was successful in gerbils 
(chapter 5, Figure 7) and showed detectable oABRs over the time course of one week (data not shown). 
However, passivation of the LED probe was not sufficient to prevent stimulation onset and offset 
artifacts, which were growing over time so that reliable ABR peak detection was not possible after one 
week. The nature of the artifact has not yet been entirely resolved: During implantation and 
subsequent bending of the fragile probe, hair-line cracks in the passivation layer could occur. This 
would allow water to reach the circuit paths through the vapor-permeable silicone layer. Additional 
passivation, based on chemical vapor deposited polymers like Parylene-C could diminish artifacts (Yang 
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et al., 2017). Another possibility would be cold plasma surface treatment for hydrophobization (Waters 
et al., 2017). 
Chronic implants would enable behavior experiments like the discrimination task based on the  well-
established shuttle-box paradigm (Wrobel et al., 2018). Thus, the question on spatial spread and 
independent channels for oCIs could be addressed also based on behavioral experiments. To match 
the needs for medical application, we have developed a mobile processor to enable optical stimulation 
in freely-moving animals (chapter 5, Figure 7) in long-term behavior experiments. 
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6 Outlook 
The development of an oCI is an intricate and multifaceted process. A number of independent 
technologies must be brought together before clinical translation to the human ear can be realized 
which essentially includes three steps. (1) Recombinant genetics: SGNs need to be genetically modified 
to allow light stimulation. Here, most likely adeno-associated viruses will be the vector of choice 
provided successful demonstration of biosafety, lack of oncogenic potential and long-term stability 
tests in higher vertebrates. (2) Biological application: the selection of the light-gated ion channel itself, 
i.e. the ChR of choice. Defining and evaluating parameters like action spectrum, gating kinetics and ion 
selectivity of available ChRs are crucial for future success. (3) Engineering technology: Development of 
appropriate linear arrays of light emitters, considering the limiting microscale dimensions of the 
intracochlear part, is critical. Here, one possible way is to place an active microscale stimulator within 
in the cochlea harboring conventional LEDs (Goßler et al., 2014; Klein et al., 2018; Park et al., 2015) or 
organic LEDs (Steude et al., 2016). Another possibility would be a passive approach using waveguides 
propagating light from an extracochlear light source (e.g. laser diode, VCSEL) to outcoupling spots 
placed along the tonotopic axis of the cochlea (Schwaerzle et al., 2016a). Further aspects to consider 
are number and pitch of the emitters, beam profile, maximum irradiance, available emission 
wavelengths and built-up of temperature, as well as energy consumption ultimately determining 
battery life.  
The number of independent channels is limited by the spatial spread of the excitation from each 
emitter and needs to be evaluated. In comparison to electrical stimulation where current readily 
spreads far from each contact, light can be spatially confined, keeping in mind the aforementioned 
technical aspects like numerical aperture and emitter size as limiting factors with regards to this. 
Additionally, knowledge about the amount of light required for auditory perception is scarce to this 
date necessitating animal behavior experiments to address this question. Furthermore, a coding 
strategy needs to be developed that will likely differ from the well-established strategies used for 
electrical stimulation. For example, while electrical stimulation does not allow simultaneously 
addressing multiple electrodes due to channel cross-talk, multiple emitters can likely be used at the 
same time for optical stimulation thus enabling stimulation patterns fundamentally different from 
currently available coding strategies. For validation, optically-evoked electrophysiological data from 
higher regions of the auditory pathway and psychophysical data are indispensable for developing 
optical coding strategies. Ultimately, if the oCI can be developed into a medical device, the 
optimization of the coding strategy will benefit from feedback of human subjects in clinical trials. 
First translation to the clinic might be achieved by using hybrid implants consisting of an oCI as well as 
a state-of-the-art eCI. Here, the eCI could act as a backup solution in case of complications with the 
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optical stimulation. Furthermore, a combination of electrical and optical stimulation could be 
discussed with a subthreshold electrical stimulus being presented prior to an optical pulse lowering 
the respective required threshold. 
However, before these can be implemented biocompatibility tests of encapsulation and passivation 
compounds (e.g. medical grade silicone) are necessary. Long-term stability tests are needed to ensure 
functionality over decades and to guarantee that metal ions or other substances used for light emitters 
are well insulated from the patient’s body. 
All these building blocks are crucial for forthcoming application of oCI in humans. This thesis takes on 
the project at an early stage of the oCI project thus addressing basic questions for future translation 
to humans. The main goal of this thesis was to demonstrate feasibility of optogenetic stimulation of 
the cochlea and lay groundwork for future oCIs. Here, the focus laid on genetic modification of SGNs, 
optimization and characterization of a promising new opsin, the study of morphological features 
enabling cochlear implantation in common animal models in auditory neuroscience and the 
demonstration of feasibility of first multi-channel oCIs in rats. Beyond the auditory field, conclusions 
can be related to the field of optogenetics and sensory restoration.
7 Summary 
This thesis introduces the ultra-fast channelrhodopsin Chronos to the auditory system matching 
temporal fidelity needed for auditory coding. We provide a comprehensive analysis of the cochlear 
morphology of animal models commonly used in auditory neuroscience laboratories. Further, we 
demonstrated, for the first time to my knowledge, first functional results with multichannel optical 
cochlear implants in rat cochleae. These preclinical studies achieved major steps towards developing 
the optical cochlear implant for clinical translation. However, many more milestones need to be 
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• Microsurgery in rodents (stereotactic injections, inner ear surgery, craniotomy)  
• Electrophysiology in anesthetized rodents 
• X-ray tomography and 3D image analysis 




Further Qualifications  
• Laboratory animal handling, management and welfare – Felasa B 
• Good Manufacturing Practice 
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• “First multichannel optical cochlear implants for optogenetic stimulation of the auditory 
pathway,” talk presented at the Conference on Implantable Auditory Prostheses (CIAP), Lake 
Tahoe, California, US, 16-Jul-2017. 
• “Characterizing optogenetic stimulation of the auditory pathway using multichannel optical CIs,” 
talk presented at the 53rd Inner Ear Biology (IEB), Montpellier, FR, 19-Sep-2016. 
• “Characterizing cochlear morphology and preliminary insertion studies with multichannel optical 
CIs,” talk and poster presented at the Restoration of Sensory and Motor Function (RSMF), 
Göttingen, DE, 26-May-2016. 
• “Ultrafast optogenetic cochlea stimulation and development of microLED implants for research 
and clinical application,” poster presented at the Conference on Implantable Auditory Prostheses 
(CIAP), Lake Tahoe, California, US, 07-Dec-2015. 
• “In vivo application of optogenetics in the auditory system,” invited talk presented at the 95th 
Annual Meeting of the German Physiological Society (DPG), Magdeburg, DE, 03-May-2015. 
• “Optogenetic stimulation of the auditory pathway in research and future prosthetics,” invited 
talk presented at the 8th Student Symposium on Molecular Medicine, Ulm, DE, 04-Apr-2015. 
• “Optogenetic stimulation of the auditory pathway,” talk presented at the 18th Annual Meeting 
of the German Audiology Society (DGA), Bochum, DE, 03-Jun-2015. 
• “Towards optogenetic stimulation of the auditory pathway: Implementing the fast 
channelrhodopsin Chronos and multichannel microLED arrays,” short talk and poster presented at 
the 38th Annual MidWinter Meeting of the Association for Research in Otolaryngology (ARO), 
Baltimore, Maryland, US, 21-Feb-2015. 
• “Establishing fast cochlear optogenetics: Chronos-based stimulation of the auditory pathway,” 
poster presented at the Conference on Channelrhodopsin et al. - Optogenetic Tools & Application, 
Würzburg, DE, 29-Sep-2014. 
• “Zukünftige Innovationen in Hörprothesen - Channelrhodopsin-2 vermittelte optische Stimulation 
der Cochlea,” invited talk presented at the 20. Friedberger Cochlea Implantat- und Hörsystem-
Symposium, Bad Nauheim, DE, 06-May-2014. 
 
